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Rationale and brief summary 
Defects in potassium spatial buffering in the brain caused by alterations in different K+ channels 
have been associated with the comorbid occurrence of epilepsy and autism spectrum disorders 
(ASD), the so termed autism-epilepsy endophenotype (AEP). This comorbid condition led us to 
hypothesize that shared pathogenetic mechanisms contribute to seizures or EEG paroxysms, and 
cognitive and socio-behavioral dysfunctions which define ASD.  
To test our hypothesis, we initially studied the relative frequency of variants in genes encoding Kir 
channel subunits. We also assessed the association of gene variants with neurodevelopmental 
disorders in patients with AEP and cranial overgrowth, analyzing two genes (PTEN and 
HEPACAM) previously reported to be associated with ASD and macrocephaly. At the same time 
we studied in vitro a new genetic variant in KCNJ2, the gene coding for Kir2.1 channels. Lastly, we 
decided to overcome the difficulties and labor-intensive single gene studies and defined in silico a 
set of potential genes collaborating and co-regulated with Kir channels and analyzed their coding 
regions adopting second generation DNA sequencing methods (NGS). To appreciate the 
significance of variants emerging by massive parallel sequencing, we characterized in vivo a 
specific gene variant found in the STXBP1 gene by using behavioural and genetic technologies in a 
zebrafish model of AEP. 
Our results suggested that in AEP the molecular mechanisms contributing to disease status likely 
related to an increase in either surface expression or conductance of Kir4.1 channels, or both. 
Although we did not find clear pathogenic links between GLIALCAM variants and AEP-
macrocephaly comorbidity, we could corroborate the role of variants in PTEN in AEP with 
macrocephaly and disclosed with NGS strategies a larger set of potential genes (mostly involved in 
glutamate transport and metabolism as well as in potassium conductance) collaborating with Kir 
channels in the pathogenesis of AEP. Both electrophysiological investigations and biochemical 
analyses in human and murine astrocytes demonstrated that Kir2.1 in AEP works stabilizing the 
plasma membrane, and influencing protein degradation and functional tests overexpressing in vivo 
the mutation p.R18Q in morphant strains of Kir4.1/KCNJ10 augmented our previous knowledge. 
The study of a new variant in STXBP1 through generation  of a stable knock-out strain in zebrafish  
suggested that STXBP1 contributes to disruption of development plan in zebrafish and to larval 
behavior, whereas heterozygous loss of gene function impairs larval movement under stress 
conditions. The mechanicistic results obtained in our study will offer solid ground to more complete 
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behavioral phenotyping in mouse models and permit high-throughput screening for molecules and 
drugs proposing new therapeutic perspectives in ASD and epilepsy. 
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1. INTRODUCTION 
1.1 AUTISM EPILEPSY PHENOTYPE (AEP) DISORDER 
The term autism spectrum disorders (ASD) is commonly used to include children with autistic 
disorder and pervasive developmental disorders not otherwise specified. This spectrum of 
neurodevelopmental disorders is characterized by lifelong impairment of social and communicative 
functioning, and by restricted, repetitive and stereotyped behaviors (Blake et al., 2013). ASD also 
affect many more boys than girls, suggesting sex-specific factors that might increase the risk in 
men, or protect women from ASD (Werling and Geschwind, 2013).  
Seizures are clinical events characterized by paroxysmal, and relatively stereotyped interruptions of 
ongoing behavior, associated with specific electrographic patterns. Although epilepsy is defined as 
two unprovoked seizures of any type, studies on autism–epilepsy have not always adhered to these 
definitions and have included children with provoked seizures as well as those with a single seizure. 
The term sub-clinical or non-convulsive seizure is used to refer to electrographic patterns, without 
clinically recognizable cognitive, behavioral, or motor functions or any apparent impairment of 
consciousness. The term “epileptiform abnormalities” is instead used to describe paroxysmal 
discharges (i.e., spikes and spike-and-wave) on an EEG. Complicating interpretations of findings 
relating to the co-occurrence of autism and epilepsy is that the standards used to determine 
epileptiform abnormalities in children with ASD, such as the type of EEG performed, have varied 
among studies looking at children with autism and epilepsy (Tuchman et al, 2010).  
The high degree of co-morbidity of autism with epilepsy (or paroxysmal EEG) has long been 
recognized, leading to the identification of an “Autism-Epilepsy Phenotype” (AEP) (Tuchman et al, 
2002). Seizures are a common comorbidity of autism, occurring at a much higher rate than that 
observed in the general population, with estimates of 6–46% of individuals with autism having 
clinical seizures at some time during their lives (Volkmar et al., 1990; Tuchman and Rapin.,1997). 
ASD is also increased in epilepsy populations, with as high as 32% of affected people that display 
some of the features of ASD (Clarke et al., 2005). There are finally several reports on the possible 
association between the presence of epileptiform activity and autistic regression. In regressive 
autism, indeed,  children appear to be developing normally and then lose eye contact, stereotypes 
and repetitive behaviors appear, and communication and social behaviors regress (Trauner, 2014). 
This strong coexistence of autism with epilepsy may probably be due to shared pathophysiological 
mechanisms that result in a developmental imbalance of excitation and inhibition, and ultimately in 
disrupted synaptic plasticity in the developing brain.  
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Despite the long recognized association between autism and epilepsy, surprisingly little is 
understood about the role that epilepsy plays in ASD. Data from the literature suggest that lower IQ, 
age, gender, and co-morbid medical conditions all increase epilepsy risk in the ASD population 
(Spence and Schneider, 2009). Moreover the co-occurrence of ASD and epilepsy in individuals 
with early onset epilepsy is most likely a different phenotype if compared with the frequent onset of 
seizures in adolescent people with ASD. The research question that needs to be addressed is 
whether there are specific causes or genes that differ in individuals with both ASD and epilepsy 
versus those with either disorder alone. The challenge is to identify these genes and the specific 
roles they play in the overlap and co-occurrence of both ASD and epilepsy. In particular the goal 
will be to identify changes in the excitatory–inhibitory balance and the cellular and molecular 
mechanisms that produce them, which may represent new therapeutic targets for treatment of these 
conditions (Brooks-Kayal, 2010). 
ASD and epilepsies are both complex disorders with many potential etiologies and 
pathomechanisms, resulting from several altered neurobiological mechanisms involved in early 
brain development, and influencing synaptic plasticity, neurotransmission, and functional 
connectivity. Most of the known genetic basis of epilepsies relate to those rare ‘monogenic’ forms 
due to mutations in genes encoding ion channels, although several genetic epilepsies have complex 
polygenic bases with an unknown number of susceptibility genes. On the other hand, ASD has been 
tied to several chromosomal abnormalities and single gene disorders, although no gene has been 
convincingly associated with idiopathic autism confirming its complexity. Also, many genetic 
disorders such as Fragile X, Rett syndrome, and tuberous sclerosis, result in the concurrence of 
ASD and epilepsy features (Brooks-Kayal, 2010). This evidence, together with multiple findings 
emerging from high-throughput genetic technologies, such as chromosomal microarray, targeted 
next-generation sequencing gene panels, and whole exome sequencing (Han et al., 2014), suggest 
that candidate genes in AEP might mainly be involved in synaptic formation and homeostasis, in 
remodeling and maintenance of neurotransmission, and ultimately in the regulation of neuronal 
excitability and inhibition.  
1.2 FUNCTION OF KIR CHANNELS IN THE BRAIN  
In the last decade, gene defects have been identified that determine different forms of epilepsy, and 
most of these genes code for ion channels (Helbig et al., 2008). Among those, the inwardly-
rectifying potassium (Kir) channel 4.1 (Kir4.1) is receiving increasing interest. Kir4.1 channels are 
expressed primarily in oligodendrocytes and in astrocytes surrounding synapses and blood vessels, 
mainly in the cortex, thalamus, hippocampus, and brainstem (Takumi et al., 1995; Higashi et al., 
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2001). They control the resting membrane potential of astrocytes and are believed to maintain the 
extracellular ionic and osmotic environment by promoting K+ transport from regions of high [K+]o, 
which results from synaptic excitation, to those of low [K+]o. This polarized transport of K+ in 
astrocytes, referred to as “spatial buffering of K+,is essential for normal neuronal activity, 
excitability, and synaptic functions. A Kir subunit possesses two transmembrane domains (TM) 
separated by a loop sequence that comprises the selectivity filter. Kir channels may exist as 
homomers, whenever four identical α-subunits are assembled. However, Kir4.1 may polymerize 
with Kir5.1 (KCNJ16) (Bond et al., 1994; Pessia et al., 1996) to form heterotetramers with 
properties that are different from the parental homomeric channels. Heteromeric Kir4.1/Kir5.1 
channels are abundantly expressed in the brainstem, mostly in the locus coeruleus (LC) (Wu et al., 
2004), and in the renal tubular epithelia where they contribute to K+ recycling (Tucker et al., 2000). 
Interestingly, loss-of-function recessive mutations of KCNJ10 (the gene coding for Kir4.1) have 
been associated with a syndrome consisting of seizures, ataxia, sensorineural deafness, intellectual 
disability, and renal salt-losing tubulopathy in two independent studies (EAST syndrome, 
Bockenhauer et al., 2009; and SeSAME syndrome, Scholl et al., 2009). The homozygous or 
compound heterozygous mutations identified in patients  with EAST/SeSAME syndrome 
compromised channel function through different loss-of-function mechanisms, including decreases 
in surface expression, mean open time reductions and a shift of pH sensitivity to the alkaline range 
(Reichold et al., 2010; Sala-Rabanal et al., 2010; Tang et al., 2010). These functional defects have 
been also proposed to underlie the renal features of the disease such as Na+ loss, hypomagnesaemia, 
hypocalciuria, hypokalemic metabolic alkalosis and activation of the renin-angiotensin-aldosterone 
system. Reports on EAST/SeSAME syndrome, however, did not mention ASD among the clinical 
findings, and intellectual disability was not an obligate symptom of the disease. Notwithstanding, a 
number of arguments substantiate that variants in KCNJ10 might contribute to brain dysfunction in 
seizures susceptibility as well as in ASD. Kir4.1 is the main glial inward conductance responsible 
for the high K+ permeability that control membrane potential and the efficient uptake of K+ by glial 
cells (Chever et al., 2010). Also, astrocytes make up 90% of all human brain cells and each 
astrocyte controls the activity of many thousands of synapses (Benarroch, 2009). Recordings from 
surgical specimens of patients with intractable epilepsies have demonstrated a reduction of Kir 
conductance in astrocytes (Bordey and Sontheimer, 1998) and of potassium clearance (Jauch et al., 
2002). Moreover, conditional knockout mice lacking Kir4.1 in astrocytes have been found to 
display premature lethality and stress-induced seizures (Djukic et al., 2007) as it is observed in 
inherited loss-of-function Kir4.1 mutations in humans (Bockenhauer et al., 2009; Scholl et al., 
2009). The relationship between KCNJ10 and ASD is less straightforward. However, a linkage 
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analysis study on a large Finnish pedigree has proposed KCNJ10 as a candidate gene for ASD 
(Kilpinen et al., 2009). KCNJ10 has also been considered as a possible player in MECP2-null mice, 
an animal model of Rett Syndrome, a monogenic syndrome featuring many characteristics of ASD 
(Zhang et al., 2010). Finally, co-occurrence of epilepsy and ASD has been reported in patients 
harboring gain-of-function mutations of KCNJ10, strongly suggesting that dysfunction in the 
astrocytic dependent K+ buffering may be a common mechanism contributing to seizures as well as 
the core behavioral features of ASD (Sicca et al., 2011). Although the loss-of-function of glial 
potassium conductance has been proposed to contribute to neuronal hyper-excitability and epilepsy 
(Orkand et al., 1966), an increased and faster influx of K+ into astrocytes due to gain-of-function 
mutations of Kir4.1 channels might also lead to larger membrane depolarization during the intense 
neuronal activity, and higher intracellular calcium elevations in these cells (Sicca et al., 2011). 
Calcium elevations in astrocytes are associated with the release of gliotransmitters, such as 
glutamate and D-serine that trigger discharges in neurons, promotes local neuronal synchrony and 
epileptic activity (Angulo et al., 2004; Bezzi et al., 1998; Fellin et al., 2004; Mothet et al., 2005; 
Parpura et al., 1994; Pasti et al., 2001; Tian et al., 2005).  A recurrent neuron-astrocyte-neuron 
excitatory loop may therefore develop at a restricted brain site, as a consequence of gain-of-function 
of Kir4.1 channels, contributing to the initiation of seizures. 
1.3 HEPACAM/GLIALCAM AND ITS ROLE IN AEP WITH MACROCEPHALY 
GlialCAM (glial cell adhesion molecule) is an Ig-like protein of still poorly characterized function, 
possibly involved in cell-matrix interactions and in cell motility (Favre-Kontula et al., 2008). It is 
predominantly expressed at cell-cell contacts between end-feet of astrocytes, and probably between 
oligodendrocytes and astrocytes (López-Hernández et al., 2011a). Disease-causing mutations in 
GLIALCAM are associated with a phenotypic spectrum including macrocephaly, 
leukoencephalopathy, and epilepsy, with or without autism, as well as intellectual disability and 
psychomotor deterioration. GlialCAM forms homo- and hetero-complexes that are reduced by 
MLC-related mutations with ensuing defective trafficking to cell junctions (López-Hernández et al., 
2011b). GlialCAM has been recently identified as a Cl− channel ClC-2 partner, targeting it to cell 
junctions and modulating its conductance (Jeworutzki et al., 2012). CLC-2 is a hyperpolarization-
activated and osmosensitive channel (Gründer et al., 1992; Thiemann et al., 1992) possibly playing 
a role in glial-mediated fluid and ion homeostasis, and in the maintenance of low extracellular 
potassium during high neuronal activity (Fava et al., 2001; Makara et al., 2003; Blanz  et al., 2007; 
Jeworutzki et al., 2012). We have hypothesized that similarly to Kir4.1 defects, an impairedion 
trafficking due to mutations in GlialCAM might cause osmotic imbalance and fluid accumulation 
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(Brignone et al., 2011; Duarri et al., 2011; Jeworutzki et al., 2012) leading to the macrocephalic 
endophenotype of AEP. Indeed, a macrocephalic endophenotype has long been described in ASD, 
but the significance of this feature is still far from being clear (Steiner et al., 2003; Chawarska et al., 
2011). Recent findings indicate that cranial overgrowth in ASD appears in the first year of life 
suggesting possible mechanisms accelerating brain growth in early development and predisposing 
to autism (Courchesne et al., 2003; Shen et al., 2013). It has also been demonstrated that 
macrocephaly associated with global somatic overgrowth may predispose to seizures in a large set 
of individuals with idiopathic ASD (Valvo et al., 2013). Shared pathogenic mechanisms might 
therefore explain concurrence of brain/cranial overgrowth, seizures (or paroxysmal EEG activity), 
and the neurobehavioral dysfunction characterizing ASD, altogether defining an even more 
selective endophenotype, the Macrocephaly-Autism-Epilepsy-Phenotype (MAEP). Mutations in the 
GLIALCAM gene (HEPACAM) have been recently identified in a spectrum of neurological 
conditions associated with macrocephaly. Biallelic, autosomal recessively inherited mutations in 
GLIALCAM were described in a proportion of the patients with the classic phenotype of 
megalencephalic leukoencephalopathy with subcortical cysts (MLC2A, MIM 613925) associated 
with ataxia, spasticity, and intellectual disability (López-Hernández et al., 2011a) and no 
identifiable variants in the more commonly involved MLC1 gene (MIM 605908). Interestingly, 
heterozygous, often de novo, mutations in GLIALCAM cause MLC2B (MIM 613926), a dominantly 
inherited condition characterized by onset of macrocephaly within the first year of life and mildly 
delayed motor development associated with white matter abnormalities on brain MRI (van der 
Knaap et al., 2010; van der Knaap  et al., 2012). In MLC2B the phenotype improves after the first 
year of life and head circumference in a few children normalizes. Most patients had delayed early 
motor and language development, which subsequently normalized in most, although some patients 
had mild residual hypotonia or clumsiness later in childhood. Intelligence was more variable, with 
intellectual disability in about half of the children, also associated with autism in a proportion of the 
cases. Seizures were a comorbid feature, though usually controlled well with medication. Brain 
MRI features were initially similar to those seen in MLC2A. On follow-up, however, all patients 
showed a significant improvement in the MRI changes, with loss of white matter swelling, 
disappearance of cysts in some cases, and lack of involvement of other brain regions. The 
association of megalencephaly with seizures and autism spectrum disorders in a subset of MLC2B 
patients raised our interests on the role played by GLIALCAM in the ASD-macrocephaly-epilepsy 
endophenotype and prompted search for allelic variants in a subset of ASD patients, either with or 
without macrocephaly or seizures. 
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1.4 PATHWAYS INVOLVED IN ASTROCYTE NEURON COMMUNICATION, LINKED 
TO AEP 
The biology of astrocyte–neuron interaction has emerged as a rapidly expanding field and has 
become one of the most exciting topics in current neuroscience that is changing our vision of the 
physiology of the nervous system. The classically accepted paradigm that brain function results 
exclusively from neuronal activity is being challenged by accumulating evidence suggesting that 
brain function might actually arise from the concerted activity of a neuron–glia network (Perea et 
al., 2009). Glia actively communicates with pre and postsynaptic neurons and influence functions 
that have long been thought to be under neuronal control. Active, bidirectional signaling between 
neurons and astrocytes influences synaptic function and plasticity in the mature brain. Emerging 
evidence also indicates that neuron-astrocyte signaling plays a pivotal role in the developing brain 
during the dynamic period when neural circuits are being formed and refined. Cross-talk between 
immature astrocytes and neurons during this critical period influences the formation and elimination 
of synapses, as well as synaptic morphology and structural plasticity. Astrocytes are well equipped 
and uniquely positioned to engage in a dynamic two-way dialogue with neurons, and can rapidly 
respond to environmental cues to influence synaptic structure and function. Although incapable of 
firing action potentials, astrocytes secrete a wide array of neuroactive ”gliotransmitters” and trophic 
factors (Barres, 2008), and they express many of the same channels, receptors, and cell surface 
molecules like neurons. Together these findings place astrocytes in a central position to actively 
signal with neurons to coordinate developing neural circuits (Stevens 2008). Neuronal activity, 
propagation of action potentials and synaptic activity after local depolarization lead to fast 
fluctuations of the extracellular K+ concentration [K+]o (Nicholson and Syková, 1998). Kir4.1 
channels are expressed mainly in oligodendrocytes and astrocytes surrounding the synapses and 
blood vessels, especially in the cortex, thalamus, hippocampus and brainstem. Their main function 
is to control the membrane potential by adjusting the concentration of K+ in the extracellular space, 
moving it from the regions in which the concentrations is greater, due to excitation synaptic, to 
those where it is smaller (spatial buffering of K+). Two conditions are necessary to make efficient 
this process, the first is that glial cells must form a syncytium in which the currents of the K+ can 
traverse relatively long distances, and the second condition is that the cells must be selectively and 
highly permeable to K+ (Orkand et al., 1966). Astrocytes form a functional syncytium which allows 
the diffusion of ions and of other intracellular signaling molecules (Nagy and Rash, 2000), through 
the presence of the gap junctions, that contribute to spatial buffering of K+. In particular Connexin 
30 and 43, that are expressed in astrocytes but not in neurons, play a fundamental role in this 
process since a knockout mouse for Connexins 30 and 43 has an increased accumulation of K+, a 
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slow decrease in the concentration of potassium and an increase of the generation of epileptic 
events (Wallraff et al., 2006). Kir4.1 and the water channel Aquaporin 4 (AQP4) are spatially 
overlapped in astroglial endfeet contacting the capillaries (Nielsen et al., 1997; Higashi et al., 2001). 
In addition, it was shown that the clearance of extracellular K+ is compromised if the number of 
perivascular AQP4 channels is decreased, giving rise to the hypothesis that K+ clearance, through 
Kir channels, might critically depend on concomitant transmembrane flux of water (Amiry-
Moghaddam et al., 2003). Similarly, impaired K+ buffering and prolonged seizure duration have 
been observed in AQP4 knockout mice (Binder et al., 2006).  Another study demonstrated that 
Kir4.1 can bind directly to α-syntrophin, requiring the presence of the last three amino acids of the 
channel (SNV), a consensus PDZ domain-binding motif (Connors et al., 2004), and it was recently 
found also that disruption of the α-syntrophin gene causes a major rearrangement of AQP4 but only 
a modest perturbation of Kir4.1 (Amiry-Moghaddam et al., 2003).  Thus, it was hypothesized that 
Kir4.1 and AQP4 may each bind an α-syntrophin molecule, allowing for both channels to be part of 
the same complex (Connors et al., 2004).  
Astrocytes express the receptors of the transforming growth factor β 1 and 2 (TGFβr1 and 
TGFβr2), and recent studies demonstrated that these receptors when activated induce a rapid 
decrease in the regulation of the Kir4.1 channels, causing a reduction of the potassium buffering. 
This determines an increase of the accumulation of the extracellular potassium, inducing the onset 
of epileptic seizures,This evidence suggests that TGFβRs might also be possible therapeutic targets 
(Ivens et al., 2007).  
Another important transporter for the K+ uptake, is the Na-K-ATPase which has a role in 
maintaining the low [K+]o level and in clearing elevations in [K+]o after epileptiform activity 
(Seifert and Steinhäuser, 2013), but another function in the brain is that the glutamate transporter 
works in concert with the α3 or  α2 Na-K-ATPase isoform to clear glutamate from the extracellular 
space, and for regulation of intracellular calcium via the Na+, Ca2+-exchanger. Na,K-ATPase is a 
heteromeric protein composed of an α catalytic subunit that binds sodium and potassium ions, ATP, 
and cardiac glycosides, and β and γ subunits that can modulate substrate affinity. Four α isoforms 
have been identified, in particular the isoform expressed throughout most regions of the brain is the 
Na-K-ATPase α2 isoform (Moseley et al., 2003). This isoform is found in astrocytes and some 
limited neuronal populations. Malfunctioning of the Na-K-ATPase pump may lead to neuronal 
hyperexcitability  by three synergistic events: elevation of extracellular K+ levels, accumulation of 
glutamate in the synaptic cleft, and increase of intracellular Ca2+ concentration (Deprez et al., 
2008). 
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According to the concept of the tripartite synapse, and to fully understand the synaptic function, 
astrocytes must therefore be considered as integral components of synapses, and of their  
physiology.  Astrocytes release several neuroactive molecules, such as glutamate, D-serine, ATP, 
adenosine, GABA, tumor necrosis factor a (TNFa), prostaglandins, proteins and peptides, that can 
influence neuronal and synaptic physiology. This process is called gliotransmission, and it was 
demonstrated that some transmitters are released in a Ca2+-dependent manner through vesicle and 
lysosome exocytosis (Perea et al., 2009). An important element in the transmission of the synaptic 
signal is the excitatory neurotransmitter glutamate. Its uptake is mainly mediated by transporters 
localized at astrocytic membranes (EAAT1 and EAAT2), and its altered activity seems to be a 
common feature in epilepsies and other brain disorders (Seifert et al., 2006). Excess of extracellular 
glutamate occurs in human epileptogenic tissue where it induces recurrent seizures and neuronal 
death (Glass and Dragunow, 1995). The correct working of this process also requires the glutamate 
receptors, which are classified in two main categories: the ionotropic glutamate receptors known as 
NMDA (N-methyl-D-aspartate) and the metabotropic glutamate receptors AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid). Deficits in excitatory synaptic density and in 
excitatory signaling through both AMPA and NMDA receptors have been found after early-life 
seizures (Brooks-Kayal, 2011). The AMPA receptors are targeted and anchored at the synapse by 
the synapse-associated protein 97 (SAP97; DLG1) and postsynaptic density 95 (PSD-95; DLG4) 
which are closely related membrane-associated guanylate kinase homologs (Maguks; Cai et al., 
2006). It was suggested that SAP97 and PSD-95 interact at, or near, synaptic sites, and the 
interaction contributes to the synaptic incorporation or to stabilize the clustered synaptic receptors 
of GluR-A AMPA receptors. This direct interaction may play a functional role in the trafficking and 
clustering of AMPA receptors (Cai et al., 2006). In vitro studies showed that PSD-95 and SAP97 
bind modulatory subunits (NR2), and two isoforms of the principal subunit (NR1-3 and NR1-4) of 
postsynaptic NMDA type glutamate receptors as well as Shaker-type K+ channels (Müller et al., 
1996). Another member of the synapse-associated proteins (SAPs) is SAP102 (DLG3); its PDZ 
domains binds the cytoplasmic tail of NR2B in vitro, and in vivo studies found direct evidence that 
SAP102 is involved in linking NMDA receptors to the submembraneous cytomatrix associated with 
post- synaptic densities at excitatory synapses (Müller et al., 1996). 
GluA1 AMPA receptor localization to spines is instead mediated by the contactin-associated protein 
(Caspr, CNTNAP2; also known as Paranodin), member of the neurexin superfamily, a group of 
transmembrane proteins that mediate cell–cell interactions in the nervous system. Its loss causes the 
formation of GluA1-containing aggregates, a mechanism that may contribute to cognitive deficits in 
CNTNAP2-associated disorders, representing a general mechanism of pathogenesis in these 
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disorders (Varea et al., 2015). Genetic variation in CNTNAP2, have been associated with 
intellectual disability, epilepsy, schizophrenia, language disorders, and autism (Varea et al., 2015). 
In addition this protein was found for the first time in the peripheral nervous system, where it was 
shown in vitro to cluster K+ channels at the juxtaparanodal region (Poliak et al., 1999).  
Calcium influx through NMDARs activates small-conductance calcium-activated potassium 
channels (SK channels; KCNN3; KCNN4) and shunts the resultant synaptic potential. SK are 
voltage-insensitive channels that have a widespread distribution throughout the nervous system, and 
when activated, by calcium influx during action potentials, result in currents that contribute to the 
after-hyperpolarization. These results demonstrate a new role for SK channels as postsynaptic 
regulators of synaptic efficacy (Faber et al., 2005).  
Loading of glutamate into synaptic vesicles is instead mediated by the vesicular glutamate 
transporters (VGLUTs). Their altered expression may affect quantal size and glutamate release 
under both physiological and pathological conditions (Ni et al., 2009), Also, changes in expression 
levels of VGLUTs have been observed to modulate the efficacy of glutamatergic neurotransmission 
and contribute to presynaptic plasticity. Different models of epilepsy, showed increased expression 
of VGLUT1 or VGLUT2 in particular brain regions (Van Liefferinge et al., 2015). Of the various 
routes for astrocytic glutamate release, the most complete evidence is for Ca2+-dependent 
exocytosis of vesicular glutamate from astrocytes. Astrocytes, like many other non-neuronal cells 
express proteins that mediate fusion of vesicles with cellular membranes, these include the SNARE 
proteins cellubrevin (VAMP3) and synaptobrevin 2 (VAMP2), the vesicular glutamate transporters 
VGLUT1/2, and synaptotagmin IV (SYT4), homologs of which are required for Ca2+-mediated 
vesicle fusion in neurons. These vesicle release proteins are, however, typically expressed at much 
lower levels than their homologs in neurons (Wetherington et al., 2008). In exocytosis/ 
neurosecretion, SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment protein 
receptors) and associated proteins play a critical role in vesicle docking, priming, fusion and 
synchronization of neurotransmitter release. Synaptic vesicles, before the release of their contents, 
dock at the pre-synaptic membrane of active zones or ribbon synapses and undergo a priming 
reaction that prepares them for exocytosis/neurosecretion. Secretion is induced when voltage-gated 
Ca2+ channels open in response to membrane depolarization, arising from action potentials. The first 
step in vesicle fusion is “tethering” where the vesicles are brought to the active zone to be attached 
to protein complexes at the presynaptic membrane of neurons. The “tethering” step is followed by 
docking of vesicles, where SNARE proteins come in contact with each other, after the docking 
there is the vesicle priming, where the SNARE proteins form a stable complex, rendering the 
15 
 
vesicles competent for fusion. The final step is the fusion of vesicles which is triggered by high 
calcium surrounding the active zone (Ramakrishnan et al., 2012). Impairment of the 
neurotransmitters release may lead to neurodegenerative diseases, as well as neurodevelopmental 
(ASD) and psychiatric disorders. Proteins at the synapse, are engaged in highly dynamic 
interactions which, when disturbed, can cause hypo- or hyper-activity in neurotransmitter release, 
leading to dysfunction (Ramakrishnan et al., 2012). Central glutamatergic synapses and the 
molecular pathways that control them are emerging as common substrates in the pathogenesis of 
mental disorders.  
Under both physiological and pathological conditions glutamate is synthesized from glutamine by 
glutaminase in neurons of the brain. After the glutamate is released from the synaptic terminal, it is 
taken up into astrocytes, where it is converted into glutamine by glutamine synthetase (GS); the 
glutamine is then transported to the neurons and reused. This ”glutamate-glutamine cycle” is an 
important component of the glutamatergic neurotransmission system, because glutamine is a 
precursor of glutamate, which is further converted into the inhibitor neurostransmitter γ-
aminobutyric acid (GABA) by glutamate decarboxylase in GABAergic neurons. GS is a 
prerequisite for efficient glutamate clearance from the extracellular space, and several studies have 
indicated that the activity of GS in astrocytes is diminished in several brain disorders, including 
epilepsy, and it has been hypothesized that the loss of GS activity leads to increased extracellular 
glutamate concentrations and epileptic seizures (Eid et al., 2013). GABA plays a crucial role in 
controlling neuronal excitability and a wide range of behaviorally relevant oscillations in the brain. 
GABAergic signals seem to be altered in ASDs. GABAergic signaling is unique in the polarity of 
its actions depends in part on the intracellular concentration of chloride that is highly labile, leading 
to depolarizing and even excitatory actions in certain conditions (Ben-Ari et al., 2012). The Cl− 
concentration gradient, between intra- and extracellular compartments, is largely due to the relative 
activity of inward astrocytic Na+/K+/2Cl−cotransporter 1 (NKCC1) (DiNuzzo et al., 2014). Up-
regulation of NKCC1 impairs GABA receptor mediated inhibition, or even converts it to excitation 
(Payne et al., 2003; Blaesse et al.,2009). Defective neuronal Cl−extrusion, due to imbalance of these 
cation-chloride cotransporters, is thought to be an important factor in epileptogenesis, because it 
might disturb the ratio of excitatory and inhibitory inputs in cortical neurons (Viitanen et al., 2010). 
Astrocytes can also release ATP, which acts in intercellular signaling between neighboring 
astrocytes, ATP can be released upon the same stimuli that trigger the release of glutamate from 
astrocytes. Under physiological conditions, released ATP is rapidly degraded to adenosine through 
ectonucleotidases (Seifert and Steinhäuser, 2013). In fact astrocytes play a key role in regulating 
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adenosine homeostasis by releasing ATP as the major physiological precursor of adenosine, whose 
physiological activity, in contrast to classical neurotransmitters, is not terminated by energy-driven 
transport systems (Aronica et al., 2013). Astrocytes regulate adenosine tone in the brain, through the 
enzyme adenosine kinase (ADK) which mediated metabolic clearance (Boison, 2008; Boison, 
2010). ADK was found to be overexpressed and associated with astrogliosis and spontaneous 
seizures (Boison, 2012).  
Regulation of neuron-glia interactions seems is due to the Eph receptors and their ephrin ligands. 
Indeed, long-term potentiation (LTP) at neuronal synapse is modulated by EphA4 (EPHA4) in the 
postsynaptic cell and by ephrinA3 (EFNA3), a ligand of EphA4, in astrocytes. Moreover, it was 
demonstrated that lack of EphA4 increases the levels of glial glutamate transporters, and ephrinA3 
modulates transporter currents in astrocytes. In addition the overexpression of ephrinA3 in 
astrocytes reduces glutamate transporter levels, produces focal dendritic swellings possibly caused 
by glutamate excitotoxicity, and exacerbated also PTZ-induced seizures. All these findings 
suggested that EphA4/ ephrinA3 signaling is a critical mechanism for astrocytes to regulate 
synaptic function and plasticity (Filosa et al., 2009). 
1.5 MODELING AEP IN ZEBRAFISH (Danio rerio)  
1.5.1 ZEBRAFISH EMBRYOGENESIS 
Zebrafish (Danio rerio) belongs to the family of barbs, the Order of Cypriniformes, Class of 
Osteichthyes, the Subphylum Vertebrates and the Phylum of chordates. It is a small teleost fish, 
which in adulthood reaches 3-4 cm in length, it has a characteristic tapered shape, and the livery has 
olive back and silver belly. The typical striae horizontal yellow (hence the name zebrafish) are 
located along the sides; they are visible on the bluish-black bottom, and extend from the capsules up 
to joining the tail. The tail fin is large enough and has the same streaks, and is divided into two 
symmetrical lobes. The embryogenesis of Zebrafish occurs at a temperature optimum of 26-28 ° C. 
Embryonic development of this fish is very fast, and the whole plan of body development is already 
defined as early as 24 hours-post-fertilization (hpf). This fast development is comparable to that of a 
human embryo in the first three months of intrauterine life. Zebrafish development has seven stages 
during the embryogenesis (Kimmel et al., 1995). 
The fertilization of the oocyte is external, and further cell divisions are incomplete and the cells 
remain interconnected by cytoplasmic bridges (Kimmel and Law, 1985). Around the tenth cell 
cycle the transcription of embryonic genes starts, and it is accompanied by the degradation of their 
maternal messengers. The notochord originates at approximately 16 hpf, the stage of 14 somites, for 
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involution of the downtown area of the cells of the neural plate. The conformation of the extension 
of the yolk will distinguish it from the front region, whereas the outline of the tail begins to protrude 
from the body embryo, and the body of myotomes generates weak muscle contractions. At the 
stadium 17 somites, weak muscle contractions (against individual somites) begin and there is a 
gradually stronger, coordinated and frequent involvement of all myotomes. The last somites arise 
more slowly with a total number that is variable between 30 and 34. The blood is now home for 
distinctive blood cells. The Pharyngula stadium corresponds to the second and third day of 
embryonic development. In this stage there is manifestation of pigment epithelium and retinal 
pigment melanophores on back-side skin with an anterior posterior gradient. The nervous system is 
hollow and expands before. The brain, in this stage, is divided into five lobes. Another feature at 
this stage is that the head embryo begins to reach out to the outside. The heart initially grows as a 
structure in the shape of a cone within the pericardial sac, in anterior to the yolk sac. The first 
heartbeats manifest at 24 hpf with irregular frequency; at the same time the sensory circuits 
reflexive, become functional. Embryos undergo the dechorionation at the end of the stadium of the 
pharyngula. The breeding period refers to the stage following the spill from the chorion, which 
generally corresponds to the third day of embryonic development. During this stage organogenesis 
is completed except for the intestines and organs related to it. From the third day the embryos 
become larvae, because they have completed much of their morphogenesis and continue to grow 
quickly. Then, important changes take place, such as inflation of the swim bladder and the 
continuous protrusion antero-dorsal of the mouth. The larvae begin to swim and to actively move 
their jaws, eyes and pectoral fin, and therefore it develops the ability to search for food and the 
larvae begin to feed themselves. 
1.5.2 ZEBRAFISH BRAIN 
The zebrafish brain, like that of any vertebrate, is subdivided into three main sections: forebrain, 
midbrain and hindbrain/spinal cord. Further subdivisions occur early on and generate specialized 
structures within these domains. (Rinkwitz et al.,  2011). The brain is the portion of the vertebrate 
central nervous system enclosed in the skull, and it is continuous with the spinal cord. It integrates 
sensory information from inside and outside the body, controls autonomic function (e.g., heartbeat 
and respiration), coordinates and directs motor responses, and is crucial to the process of learning.  
The forebrain can be divided into two main regions, telencephalon and diencephalon, and it is the 
most rostral part of the three primary divisions of the developing vertebrate brain or the 
corresponding part of the adult brain. It is the main control center for sensory and associative 
information processing, visceral functions, and voluntary motor functions. The diencephalon is the 
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caudal subdivision of the embryonic forebrain. It is located at the midline of the brain, above the 
mesencephalon. The diencephalon contains the thalamus and hypothalamus; the former serves to 
relay impulses, especially sensory impulses, to and from the cerebral cortex, while the 
hypothalamus is responsible for certain metabolic processes and other activities of the autonomic 
nervous system. This subdivision of the forebrain includes also the habenula that is either of two 
nuclei, of which one lies on each side of the pineal gland under the corresponding trigonum 
habenulae. It is composed of two groups of nerve cells, is connected to its contralateral counterpart 
by the habenular commissure, and it forms a correlation center for olfactory stimuli. The habenula 
relays impulses from limbic areas of the telencephalon to an unpaired midbrain nucleus, the 
interpeduncular nucleus. The telencephalon is the rostral subdivision of the embryonic forebrain or 
the corresponding part of the adult forebrain that includes the cerebral hemispheres and the 
associated structures, it includes the olfactory bulb, the pallium and the subpallium. The olfactory 
bulb, a bulbous projection of the olfactory lobe, is the place of termination of the olfactory nerves. It 
is the most rostral part of the brain, and is involved in olfaction, while the pallium is the mantle of 
grey matter forming the cerebral cortex. It coordinates sensory and motor information. The 
subpallium is the ventral telencephalon; in the fish it corresponds to the mammalian basal nuclei, 
including the striatum, the key recipient of dopaminergic reward in the mammalian brain. The 
pallium shares with the subpallium inputs from the locus coeruleus (noradrenergic input), and the 
superior raphe (serotoninergic), whereas the subpallium additionally receives such inputs from the 
posterior tuberculum (dopaminergic), the superior reticular nucleus (putative cholinergic), and the  
caudal hypothamalic zone (putative histaminergic) (Rink and Wullimann, 2004). 
The midbrain is the region between the forebrain (located anteriorly) and the hindbrain 
(posteriorly), and lies between the tectum dorsally and the midbrain tegmentum ventrally. It is 
known also as mesencephalon, and it is subdivided into optic tectum and tegmentum. The optic 
tectum is the roof of the midbrain; it is morphologically visible by the end of the segmentation 
period, whereas the tegmentum is the part of the ventral midbrain above the substantia nigra, 
formed of longitudinal white fibers with arched transverse fibers and gray matter.  
The hindbrain is the most caudal section (rhombencephalon) and includes the metencephalon and 
the myelencephalon. It controls autonomic functions and system equilibrium. The metencephalon is 
the rostral segment of the developing vertebrate hindbrain or the corresponding part of the adult 
brain composed of the cerebellum and pons. The cerebellum is a large, dorsally projecting part of 
the brain concerned especially with the coordination of muscles and the maintenance of bodily 
equilibrium. The myelencephalon is the caudal part of the developing vertebrate hindbrain or the 
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corresponding part of the adult brain composed of the medulla oblongata. The medulla oblongata is 
the most caudal portion of the brain, it is in contiguity with the spinal cord and enclosing the fourth 
ventricle. It contains various centers mediating the control of involuntary vital functions. 
The spinal cord is the thick longitudinal cord of nervous tissue that extends along the back dorsal to 
the body and it is enclosed in the vertebral canal formed by neural arches. It is rostrally continuous 
with the medulla oblongata, gives off at intervals pairs of spinal nerves to various parts of the trunk 
and limbs, serves as a pathway for nervous impulses to and from the brain, and as a center for 
carrying out and coordinating many reflex actions independently of the brain. The spinal cord is 
composed largely of white matter arranged in columns and tracts of longitudinal fibers about a large 
central core of grey matter. 
1.5.3 ZEBRAFISH AS ANIMAL MODEL FOR NEUROLOGICAL DISORDERS 
The zebrafish as a vertebrate model organism has been used in numerous studies of the various 
aspects of neurogenesis. Similar to mice and fruit flies, zebrafish can be used for genetic analysis. 
In contrast with mammals, the development of fish larvae occurs externally, making the zebrafish 
CNS accessible for experimental manipulation. In addition, optical methods as high-speed and high-
resolution microscopy, as well as new manipulative tools in the emerging field of optogenetics can 
be applied to this model organism. Thus, a unique combination of genetics, embryology, and state-
of-the art optical techniques makes the zebrafish a unique model organism to study neurogenesis. 
The majority of studies conducted so far focus on neurogenesis at embryonic stages. However, 
recent studies have shown that the mature zebrafish brain may also serve as a valuable tool to study 
adult neurogenesis (Schmidt et al., 2013). Recently zebrafish became a valuable tool for 
neurobehavioral studies because larvae display several, quantifiable behavioral phenotypes that may 
recapitulate human behaviors. This model is also useful for high-throughput drug screening, 
because zebrafish has the capacity to lay a lots of eggs, consequently producing an elevate number 
of small size larvae, that are useful to test drugs in up to 96-well plates, since they can survive in a 
small volume of water and few milligrams of compounds (Best and Alderton, 2008). There are 
differences between the zebrafish brain and the human brain, however. As an example, the 
telencephalon does not develop into a layered cortex. However there are also structures highly 
homologous such as habenula, layered structure of the cerebellum, the hypothalamus and its 
neuroendocrine systems. In addition, most of the neurotrasmitters and neuropeptidergic system 
(Becker and Rinkwitz, 2012) are highly similar between the two brains. Over the past decade, 
zebrafish has received an enormous boost as a disease model through the introduction of molecular 
technologies such as antisense oligonucleotides (morpholinos) for early knockdown of gene 
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function (Nasevicius and Ekker, 2000), and the recovery of mutations in a gene of interest from 
mutagenized libraries of fish (Targeting Induced Local Lesions In Genomes, TILLING) (Wienholds 
et al., 2003). Recently, new efficient strategies of gene editing of zebrafish were developed such as 
the TALEN system (Transcription activator-like effector nucleases) which are artificial restriction 
enzymes generated by fusing a TAL effector DNA-binding domain to a DNA cleavage domain 
(Bedell et al., 2012), and, even more recently, CRISPRs (clustered regularly interspaced short 
palindromic repeats). The latter consists in delivering the Cas9 protein and appropriate guide RNAs 
into a cell, and the organism's genome can be cut at any desired location (Hwang et al., 2013a). The 
other advantage of using zebrafish for post-genome neurobiology is that there is a large collection 
of gene expression patterns, as well as available mutant and transgenic strains. All these aspects 
underlie the fact that zebrafish is a powerful model organism for forward genetics, and also for 
reverse genetics with the advent of tools allowing targeted mutation in a relatively easy and rapid 
manner (Gonzalez et al., 2010). With its transparency and small brain, the zebrafish is a perfect 
model animal for monitoring brain activity with calcium imaging. The introduction of two-photon 
microscopy to calcium imaging in zebrafish (Yaksi and Friedrich, 2006) allowed optical sectioning 
of brain tissue non-invasively. While the optical monitoring of brain activity was transforming 
neurophysiology, another revolution in neuroscience was taking place: optogenetics, a novel 
technique that uses light to activate or silence genetically altered neurons (Wyatt et al., 2015).  
Zebrafish is also excellent to studying epilepsy. It was demonstrated that using behavioral, 
molecular, pharmacological and electrophysiological techniques, immature zebrafish have seizures 
when exposed to the common convulsant drug pentylenetrazole (PTZ) reproducing many of the 
crucial aspects of mammalian seizures (Baraban et al., 2005; Hortopan et al., 2010a). Baraban and 
co-workers identified and characterized the first mutant zebrafish models of epilepsy, including 
Ube3a (Angelman’s syndrome) (Hortopan et al., 2010b), Scn1a (Dravet syndrome) (Baraban et al., 
2013), and Ocrl1 (Lowe’s syndrome) (Ramirez et al., 2012), using zebrafish mutants emerging from 
forward-genetic ENU-based screens. In zebrafish, field potential recording of synchronized neural 
activity can readily be performed in series with behavioral tracking experiments allowing 
unequivocal confirmation of epilepsy in these models. The miniscule size of larval zebrafish 
currently prevents the simultaneous recording of behavior and EEG, but zebrafish offer several 
unique advantages in epilepsy research. For example, zebrafish membranes are permeable to drugs 
placed in the bathing medium. The ease with which drugs can be delivered to freely behaving 
zebrafish and the sensitivity of locomotion and electrophysiology assays for seizure activity have 
favoured novel moderate- to high-throughput platforms for the discovery of innovative anti-
epileptic drugs (AEDs) (Grone and Baraban, 2015).  
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It is also feasible to model autism disorders using zebrafish as tool because candidate regions of the 
brain that are affected in patients with ASD are also represented in the fish brain, and are under 
similar genetic control. In addition, existing zebrafish mutants that perturb these regions indicate 
that fish model can productively be used to study ASD. Also, behavior in zebrafish likely correlates 
with some human behaviors seen in autism. Teleosts have a wide range of simple and complex 
behaviors all of which appear to be largely comparable with humans (Tropepe and Sive, 2003). 
Most of the zebrafish behavior can be analyzed through the use of automatic tracking systems that 
allow obtaining quantitative data. The shoaling behavior, namely the preference of the fish to swim 
in a shoal with the others, is one of the most important social behaviors that are investigated while 
reproducing ASD in zebrafish, This social aspect can be evaluated through the use of three different 
types of test known as i) shoaling test, ii) social preference test and iii) mirror beating test. All these 
tests may be helpful to understand the impairment of social functioning seen in children with 
autism, though it is obvious that no single model can fully recapitulate the whole of a complex 
human disorder such as ASD. 
 
22 
 
2. HYPOTHESIS AND AIMS 
The work hypothesis of the three-year project discussed in this experimental doctoral thesis is that 
dysfunction of the astrocytic-dependent machinery modulating neuronal microenvironment and 
synaptic function may have implications in autism-epilepsy phenotype (AEP).  
To tackle this research question, we identified the principal aims in this thesis are: 
1. To expand the array of gene variants in genes encoding Kir channels. The objective of the 
first year of the project was to broaden the molecular analysis of the KCNJ10, KCNJ16 and 
KCNJ2 genes in a large cohort of patients with AEP correctly classified in terms of clinical, 
neuropsychological, and neurophysiological information. We also plan to assess the 
association of gene variants with neurodevelopmental disorders in patients with AEP and 
cranial overgrowth, analyzing two genes (PTEN and HEPACAM) previously reported to be 
associated with autism and macrocephaly. 
2. To focus with methods of next generation sequencing on a larger set of gene variants 
modulating astrocyte-neuron communication at tripartite synapses and likely contributing to 
the genetic assortment of AEP.  
3. To characterize functionally gene variants in vivo by using advanced behavioural and genetic 
technologies in a zebrafish model of AEP. 
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3. MATERIAL AND METHODS 
3.1 AEP SAMPLE COLLECTION AND DNA EXTRACTION 
The sample was selected from our research database that included all ASD children who underwent 
EEG recordings in our clinical unit, and whose parents gave informed consent for collecting and 
storing clinical data and DNA for genetic analyses. Total genomic DNA from peripheral blood was 
obtained from patients using standard, salting-out purification protocols.  
3.2 GENETIC ANALYSES 
The coding exons and exon-intron boundaries of KCNJ10 (NM_002241, NG_016411), KCNJ2 
(NM_000891.2), and  KCNJ16 (NM_018658) were amplified by polymerase chain reaction (PCR) 
amplification using primer oligonucleotides designed with Primer 3. The coding exons and exon-
intron boundaries of GLIALCAM (accession number NM_152722.4) were PCR amplified using 
oligonucleotide primers and conditions outlined elsewhere (López-Hernández et al., 2011). The 
PCR products were purified with Exo- Sap (USB, Cleveland, OH) and bidirectionally sequenced 
using the BigDye v3.1 chemistry (Applied Biosystems Foster City, CA). Chromatograms were 
analyzed using SeqScape Software (Life Technologies). Synonymous, missense and splice site 
variations were systematically evaluated for modifications of exonic splicing enhancers (Polyphen 
analysis, http://genetics.bwh.harvard.edu/pph/; SIFT analysis (http://sift.jcvi.org/); Mutation Taster 
analysis, http://www.mutationtaster.org/; ESEfinder, http:// rulai.cshl.edu/cgi-
bin/tools/ESE3/esefinder.cgi) or consensus splicing sequences in order to determine the splice site 
score (rulai.cshl.edu/new_alt_exon_db2/HTML/score.html and 
www.fruitfly.org/seq_tools/splice.html). We also analyzed the exons and the flanking intronic 
regions corresponding to PTEN (NM_000314.4) in the 31 individuals with macrocephaly. PCR 
reactions were performed using 50 ng of genomic DNA as template and FastStart Taq DNA 
Polymerase (Roche, Mannheim, Germany). PCR products were purified and bidirectionally 
sequenced as stated above. 
3.3 TARGETED NEXT-GENERATION SEQUENCING (NGS) AND ANALYSIS 
Total genomic DNA was purified from whole blood using the MagNA Pure Compact Nucleic Acid 
Isolation Kit I (Roche, Penzberg, Germany), according to the manufacturer’s instructions. All 
samples were quantified with the Qubit dsDNA BR assay kit (Invitrogen, Eugene, OR). Probes for 
NGS studies were designed on the coding regions (http://genome.ucsc.edu/) of 35 genes using 
DesignStudio software (Illumina, San Diego, CA). The parameters selected were: i) bait length 250 
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bp, ii) probes covering the coding regions and at least 25 bp of flanking intronic sequences; iii) skip 
of known single nucleotide polymorphisms (SNPs) in the design. The total target region, which was 
defined as the region covered by one or more amplicons, was 208213 bp and was analyzed with 
1456 amplicons. The coding regions were captured using the TruSeq Custom amplicon kit 
(Illumina) according to the manufacturers’ instructions, and sequenced in a MiSeq genomic 
analyzer using a standard protocol. In particular, purification of the libraries used AMPure beads 
(Beckman Coulter Inc., Pasadena, CA) and equimolar pools were produced for enrichment, diluted 
in hybridization buffer, and heat denatured before cycles-sequencing. The other experimental 
procedures followed the standard Illumina protocol 
(http://support.illumina.com/sequencing/sequencing_kits/truseq_custom_amplicon.html). 
Sequencing data were de-multiplexed, aligned to the reference human sequence (GRCh38.p2), and 
subjected to variant automatic calls using Illumina Variant Call Analysis. The variant selection 
criteria for single nucleotide variations (SNVs) and small insertions and deletions (in/del) were: i) at 
least 50% of the reads indicating the variation, ii) a mean quality (QC) score ≥20; iii) coverage of at 
least 30X using IGV Software (http://www.broadinstitute.org/igv/). Analyses of data and biological 
interpretation adopted Ingenuity Variant Analysis (IVA, www.ingenuity.com/products/variant-
analysis, QIAGEN, Germany).  
Novel nonsense or frameshift were regarded as pathogenic whereas missense were systematically 
evaluated in silico for their putative functional consequences using Polyphen2 
(http://genetics.bwh.harvard.edu/pph2/) and SIFT (http://sift.jcvi.org/) predictions. To better 
classify the identified SNVs, we adopted a class definition based on the following criteria: (1) 
coding/non-coding, if the changes were in the coding sequence or not; (2) unknown/known, if 
variants were new or already reported in public available large exome databases including 1000G 
Project (http://www.1000genomes.org/), ESV6500 (evs.gs.washington.edu), dbSNP132 
(http://www.ncbi.nlm.nih.gov/SNP/), and ExAC (exac.broadinstitute.org); (3) high/low allele 
frequency, if the minor allele frequency (MAF) of the individual changes was >1% or more rare; (4) 
predictably deleterious or not, based on in silico result of predicting functional tools. Based on the 
aforementioned four characteristics, we then sorted variants in 13 subgroups (from A to N) and 
defined four major subgroups based on frequency, possible damage to protein function, and location 
in coding exons. All coding variants with a read depth ≥30X were confirmed using Sanger 
sequencing and tested for segregation in parents and relatives whenever their DNA was available. 
Sanger sequencing using BigDye v3.1 chemistry (Applied Biosystems Foster City, CA) served also 
to fill in coding exons not fully covered by TruSeq amplicon design. Chromatograms were analyzed 
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using SeqScape Software (Life Technologies Europe, Monza, Italy). Variants predictably 
deleterious underwent further correlations to clinical features recorded in the diverse clinical 
subgroups of patients (MAEP, AEP, and “simplex” ASD), including information on the regressive 
onset of ASD, tall stature, macrocephaly, level of cognitive and language development, and 
prevalent site of EEG abnormalities. Statistical analyses were performed using IBM© SPSS© 
Statistics software version 20 (Armonk, New York, NY). To this end, we considered, as continuous 
variables, the number of variants detected in each gene belonging to a given mutation class. 
Analyses were performed using two tailed t-test, two-way analysis of variance (ANOVA), and post-
hoc multiple comparisons through the Bonferroni method. The option “exclude cases analysis by 
analysis” was selected to manage missing data. Significance was set at p<0.05.  
3.4 ZEBRAFISH MAINTENANCE AND BREEDING 
Experiments on Kcnj10a were performed in accordance with, and under the supervision of, the 
Institutional Animal Care and Use Committee (IACUC) of the University of Pisa and the IFC-
National Research Council, and were conducted in our zebrafish core facility and every effort was 
made to minimize animal suffering. We used the minimum number of animals necessary to collect 
reliable scientific data. The wild type zebrafish strain used was AB. For Stxbp1a adult male and 
female wild type zebrafish (TL and WIK strains) were obtained from the Zebrafish International 
Resource Center (Eugene, OR; http://zebrafish.org/zirc/fish/lineAll.php). Zebrafish were 
maintained according to standard procedures (Westerfield, 2000) and following guidelines 
approved by the University of California, San Francisco Institutional Animal Care and Use 
Committee. For both experiments the zebrafish room was maintained on a 14hr light:10hr dark 
cycle, with light on at 9:00AM and lights-off at 11:00PM. Zebrafish embryos and larvae were 
maintained in egg water unless otherwise stated. 
3.5 IN SITU HYBRIDIZATION 
Whole mount in situ hybridization was performed only for Stxbp1a and Stxbp1b.  Templates for 
riboprobes were generated by PCR amplification of zebrafish genomic. Probes were designed to be 
complementary to the exon 7. The T3 promoter sequence (aattaaccctcactaaaggg) was added to 
either the reverse primer (for the antisense probe) or the forward primer (for the sense control). 
DNA using primers with the sequences: Stxbp1a-F: CTGACGCCTTCCAGAGTTTC, Stxbp1a-R: 
CCTCAGCATCTGTTCCCATT; Stxbp1b-F AGTACCAGGGCACAGTGGAC, Stxbp1b-R 
AACAGTGAGGTGGGGCTATG. Digoxigenin-labeled riboprobes were transcribed in vitro using 
standard reagents including DIG RNA labeling mixes (Roche Molecular Biochemicals), Fermentas 
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T3 RNA Polymerase, RNAse out, and were then treated with DNAse and purified using GE 
Healthcare illustra ProbeQuant G-50 Micro Columns. ISH was performed following standard 
protocols. Larvae were fixed in 4% paraformaldehyde (pH 7.0) in phosphate-buffered saline (PBS) 
at 4°C overnight. Following fixation, larvae were rinsed 4X for 5 minutes in PBS with 0.1% Tween 
20 (PBSTw). Larvae were then rinsed with 100% methanol for 5 minutes, transferred to fresh 
methanol, and subsequently stored in 100% methanol at -20°C until needed. Before 
experimentation, brains and larvae were rehydrated in PBS, and brains were dissected using 
forceps. Brains were then processed and stained in wells of a 24-well plate in incubation baskets 
(Intavis AG). Brains were rehydrated through a series of 5-minute washes in 75%, 50%, 25% 
methanol in PBS with 0.1% Tween (PBS/Tw). Brains were then washed twice for 5 minutes in 
PBS/Tw, treated with proteinase K for 5 to 10 minutes, and rinsed 4 times with PBS/Tw. Brains 
were fixed again with 4% PFA for 10 minutes at room temperature, washes 4 X5 min in PBST. 
Prehybridization (1 hour) and hybridization (overnight) were carried out at 58°C, in a hybridization 
buffer containing 50% Formamide, 5X SSC buffer, 5mg/mL yeast torula RNA, and 0.1% Tween. 
Posthybridization washes were carried out at 58°C: twice for 30 minutes in 50% Formamide, 2X 
SSC w/Tw, once for 15 minutes in 2X SSC w/Tw, and twice for 30 minutes in 0.2X SSC w/Tw. 
Tissues were then blocked for 1 hr in blocking buffer containing 100mM maleic acid, pH 7.2, 
150mM NaCl, bovine serum albumen (BSA), sheep serum, and 0.1% Tween 20. Alkaline-
phosphatase-conjugated anti-DIG Fab fragments (Roche) were then added to the blocking solution 
to a final dilution of 1:4000. Brains were incubated overnight at 4°C, then washed 4 times for at 
least 10 minutes each in Maleate Buffer and signal was revealed with NBT/BCIP (Roche), kept in 
the dark, at room temperature or 37°C. To stop the staining reaction, tissue was washed 5 times for 
5 minutes in PBS w/Tw. 
3.6 QUANTITATIVE REAL-TIME PCR (qPCR) 
Gene expression levels of stxbp1a and stxbp1b mRNA were examined using RNA pooled from 10 
WT sibling larvae. Total RNA was extracted using Trizol® Reagent (Invitrogen, Carlsbad, CA), 
treated with DNAse (Ambion/Applied Biosystems, Austin, TX) and quantified with NanoDrop™ 
ND-1000 spectrophotometer (Thermo Scientific). Reverse-transcription reactions were performed 
using SuperScript™III First-Strand Synthesis System (Invitrogen) with a mix of oligo(dT)20 and 
random hexamers. The cDNA templates were diluted 1:2 with DEPC sterile water. The qPCR 
reactions were performed using SybrGreen® fluorescent master mix on an ABI Prism® 7700 
Sequence Detection System using ABI PRISM SDS v9.1 software (Applied Biosystems). Zebrafish 
stxbp1a cDNA was amplified using the following primers, which were designed using Primer 
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Express v3.0 (Applied Biosystems): stxbp1a_qF1: TTGCTGGATGCCAATGTCA; stxbp1a_qR1: 
TCCGTGATCCCGTTCTTGAG. The following primers were used to amplify β-actin cDNA 
(GenBank Accession # FJ915059) for data normalization: β-actin-F: 
CATCCATCGTTCACAGGAAGTG; β-actin-R: TGGTCGTTCGTTTGAATCTCAT. Samples 
were run in triplicate and reactions contained 1× SYBR green master mix, 10 µM of each primer, 
and RNAse free water for a final volume of 10 µl. Samples without reverse transcriptase were run 
for each reaction as negative controls. Cycling parameters were as follows: 50°C × 2min, 95°C × 
10min, then 40 cycles of the following 95°C × 15s, 60°C × 1min. For each sample a dissociation 
step was performed at 95°C × 15s, 60°C × 20s, and 95°C × 15 s at the end of the amplification 
phase to check for the presence of primer dimers or non-specific products. For both genes, qPCR 
efficiencies were assessed by mean of 4-fold serial dilutions of pooled cDNA. Serially diluted 
cDNAs were used to construct standard curves and estimates of efficiencies, slope of the curves and 
the correlation coefficient. Triplicate quantification values (CT; cycle threshold) were analyzed 
using qCalculator software (programmed by Ralf Gilsbach) which estimates qPCR efficiency E= 
10(– 1/slope) and the relative gene expression between samples after normalization basing on both 
the Comparative ∆∆CT (Livak and Schmittgen, 2001) and the Efficiency Based (Pfaffl, 2001) 
methods.  
3.7 CRISPR/Cas9 SYSTEM TO GENERATE TRANSGENIC (STXBP1) MODELS 
To generate STXBP1 knockout models, CRISPR/Cas9 mutations were generated in wild type (TL 
strain) zebrafish using published techniques (Hwang et al., 2013a; Hwang et al., 2013b). Sequence-
specific sgRNA template plasmids were generated for each target site by modifying DR274 
(Addgene Plasmid #42250). Plasmid Dr274 was modified to contain sequence specific sequences 
selected using ZiFit (http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx). In order to avoid off-target 
genomic mutagenesis effects, which can occur at sites that closely resemble the target site, we 
selected target sites that had a minimum of three (3) mismatches with every other site in the 
genome. The sequences of the modified plasmids were verified by capillary Sanger sequencing. 
sgRNAs were transcribed from linearized template plasmids (Ambion MEGAscript T7/SP6), and 
purified (Ambion MegaClear Kit). Cas9 mRNA was transcribed in vitro from linearized template 
plasmid MLM3613 (Addgene Plasmid #42251). Fertilized 1-2 cell stage zebrafish eggs were 
injected with an injection mix containing approximately 300ng/µl Cas9 mRNA and 15 ng/µl 
sgRNA, fertilized 1-2 cell stage zebrafish eggs were inject. After injected eggs were incubated for 
one day, some were harvested to check for mutagenesis at the target site. DNA was extracted from 
pools of 10 injected embryos and uninjected controls, gDNA including the target site was amplified, 
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and the target site was checked via Sanger sequencing. Multiple sequencing peaks were confirmed 
to be present at the sgRNA target site before proceeding. Other Cas9/sgRNA-injected embryos were 
raised to adulthood. These F0-generation potential mutants were crossed, and DNA was extracted 
from pooled F1 embryos for PCR and sequencing, as performed on the injected embryos. To obtain 
stable lines with known mutations, F1 embryos were raised to adulthood and outcrossed to wild 
type (WIK strain) zebrafish. For adult fish of each line, genomic DNA was extracted from tail 
tissue, amplified by PCR, cloned into TOPO pcr2.1 vector, and sequenced. Mutations were 
identified and multiple individuals from each line were sequenced to confirm that each individual 
carried the same mutation. For genotyping, we extracted genomic DNA from whole larvae using the 
Zebrafish Quick Genotyping DNA Preparation Kit (Bioland Scientific). We amplified stxbp1a 
gDNA using the following primers: stxbp1a-F: CACACACTTACAGCAGGAATGAGTGG, 
stxbp1a-R: ATTCAGACTTCAACTGTACATGTATTGTG. These primers amplify a 275-bp 
region including the stxbp1a mutation site. The mutant allele is then detected by digesting the 
amplicon with the endonuclease BsaHI since the presence of the mutation abolishes a site of 
cleavage. Digested samples were electrophoresized on a 1% agarose gel. This newly generated 
mutant allele is designated stxbp1as3000, using the University of California San Francisco (UCSF) 
“s” designation in accordance with the Zebrafish Information Network (ZFIN) guidelines. 
3.8 ZEBRAFISH BEHAVIOR: MOBILITY TRACKING 
For locomotion tracking, single zebrafish larvae were placed in individual wells of a 96-well flat-
bottomed Falcon culture dish (BD Biosciences). Each well contained approximately 200 µl of 
embryo medium. Behavior was monitored at room temperature (21-22°C) using a DanioVision 
system and EthoVision XT 8.0 locomotion tracking software (Noldus Information). Five dpf larvae 
were allowed to acclimate to the tracking arena for 3 to 4 hours, and then 24 hours of continuous 
behavioral data were recorded beginning at 4:00PM. The light/dark cycle continued as usual: lights-
off occurred at 11:00PM and lights-on at 9:00AM. At 4:00PM, when the 24 hour recording was 
completed, we tested larvae responses to sudden changes in light intensity. Six dpf larvae were 
exposed to 10 sec of darkness (0% intensity light) followed by 10 sec of 100% intensity light. Using 
EthoVision XT 8.0 software, we analyzed parameters of distance, movement, and velocity for 
individual locomotion plots. 
3.9 KCNJ10a KNOCKDOWN USING MORPHOLINO ANTISENSE OLIGOS 
To knock-down the gene function, we used morpholinos (Gene Tools, USA) targeting the splice site 
(5-AATT - GTGAGAGCTATACCTTGGCGA-3) of ZF kncj10a (MO-splice), diluted into RNAse 
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free water, and injected into one- to two-cell stage ZF, which were raised at 28.5°C. At 30 hpf, the 
ZF were still in their chorion and were placed in a 12-well plate and equilibrated for 3 minutes. 
Then, we recorded embryo movements for 180 seconds and counted the number of complete tail 
contractions occurring in 15 wild type and 15 morphants in 30 seconds time frames. For rescue 
experiments, human WT and R18Q cDNAs were cloned in a PCS2+ vector. The capped mRNA 
was obtained using mMESSAGE mMACHINE SP6 transcription Kit (Life technologies). Then, 50 
pg human WT or R18Q mutant KCNJ10 cRNA was co-injected with 0.5 ng of kcnj10a MO-splice. 
In 30 hpf embryos (mutant and wildtype) wideo recording of 180 sec was made Leica M80 
microscope with Nikon Digital Sight DS-Fi1 camera and the NIS Elements software package 
(Nikon, Nikon Corp., Europe), and a digital video camera (30 frames per second) using the 
CamStudio software. We counted tail flicks in video records and data were placed in Prism 
(GraphPad) to generate graphs and perform statistical analyses (unpaired two-tailed Mann-Whitney 
U-test of all pairwise combinations). 
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4. RESULTS AND SPECIFIC COMMENTS 
4.1 GENETIC ANALYSES IN GENES ENCODING KIR CHANNELS 
Results 
Screening for variants in KCNJ10 (Kir4.1), KCNJ16 (Kir5.1) and KCNJ2 (Kir2.1) detected 4 
missense variants in KCNJ10 (R18Q, V84M, R348H, R271C) in a total of 19\175 (10.8%) 
individuals, and one change in KCNJ2 (K346T) in two identical twins (Tab.1). 
 
Table1. Kir channels genetic analysis 
 n = 
175 
  KCNJ10  KCNJ2 KCNJ16 
  R18Q V84M R348H R271C K346T  
AEP 137 5 1 1 9 2 0 
ASD 
simplex 
38 2 0 0 1 0 0 
 
A heterozygous missense c.53G>A (p.R18Q) at the cytoplasmic N-terminus of the protein was 
detected in 7/175 (4%) individuals (2/7 were identical twins). The variant was inherited from the 
mother in 4 cases (57%) and from the father in 2 (29%); in a single case, parental DNA was not 
available. 
The reported c.811C>T (p.R271C) in KCNJ10 (rs1130183) was detected in 10/175 (5.7%) 
individuals. The variant was inherited from the mother in four and from the father in two cases. In 
one patient, both parents carried the variant and we could not attribute the right genetic phase. 
Parental DNA was not available in 3 cases.  
The c.250G>A (p.V84M) was found in a boy, and was inherited from his mother (Sicca et al, 
2011). The patient had a diagnosis of AEP with no regressive onset, and displayed focal seizures 
and anterior EEG abnormalities. He had delayed language development and severe intellectual 
disability.  He also showed self-injurious behaviors and aggressiveness.  
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The missense c.1043G>A (p.R348H) in KCNJ10 (rs146396982) was detected in a girl and her 
father. The patient had a clinical diagnosis of ASD (regressive onset) and epilepsy. She displayed 
spasms since she was aged 4months. Spasms remitted at six months after a fever. She also showed 
EEG abnormalities and the language was absent. Her cognitive development was severely delayed.   
In order to correlate KCNJ10 variants with phenotypic features in our patients, we initially analyzed 
two groups: (1) Wild Type (WT) [156/175 (89.2%)] vs (2) cases harboring variants in KCNJ10 
[19/175 (10.8%)]. 
The two groups were similar with respect to age, gender, ASD diagnosis, language, cognitive 
development, type of onset of ASD (regressive vs non regressive), presence of behavioral problems 
and sleep pattern, auxological parameters, and family history for neuropsychiatric disorders. 
KCNJ10 variants were significantly associated with seizures when compared with WT patients (χ 2 
=6.823, df=1, p=0.009) (Table2), and in particular with epileptic spasms. 
Table2.  KCNJ10 variants: genotype-phenotype correlation 
 WT 
(n=156) 
KCNJ10 
Variants 
(n=19) 
Test Effect p 
Seizures   χ2 = 6.823 Φc=0.197 0.009* 
Yes 51 (32.7%) 12 (63.2%)    
No 105 
(67.3%) 
7 (36.8%)    
EEG 
abnormalities 
     
Yes 113 
(76.9%) 
16 (88.9%) χ2 =1.358 Φc=0.091 0.244 
No 34 (23.1%) 2 (11.1%)    
Site  of EEG 
abnormalities 
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Anterior 39 (34.5%) 5 (31.2%) χ2 =1.282 Φc=0.100 0.734 
Posterior 17 (15%) 1 (6.2%)    
Temporal 15 (13.3%) 3 (18.8%)    
Multifocal/Diffuse 42 (37.2%) 7 (43.8%)    
Type of EEG 
abnormalities 
     
Paroxysms 57 (50.4%) 6 (37.5%) χ2 =1.465 Φc=0.107 0.481 
Focal slowing 17 (15%) 2 (12.5%)    
Both 39 (34.5%) 8 (50%)    
 
χ
2
=the Pearson chi-squared test; Φc= Cramers’ phi coefficient; *KCNJ10 variants were associated 
with presence of seizures 
Interestingly, all children did not display other seizures following epileptic spasms indicating a 
particularly good prognosis of their epilepsy. The two groups did not differ in frequency, type and 
site of EEG abnormalities (Table 2). Finally, we observed that individuals having variants in 
KCNJ10 showed a lower frequency of stereotyped behaviors (p=0.009) (Table 2). The analysis 
conducted only taking into account children harboring the R18Q variant vs WT showed that spasms 
were significantly over-represented in the mutant children (p=0.001). A similar trend was observed 
analyzing only children carrying the R271C, though without reaching a statistic significance  . 
Variants R348H and V84M, each occurring in a single case, could not undergo statistical analysis.  
The genetic analyses of the KCNJ16 did not reveal any new variation, while those in KCNJ2 
identified the novel c.1037A>C/p.K346T, located in the cytoplasmic C-terminus domains of Kir2.1. 
The latter variant was detected in two identical twins, also carrying the R18Q in KCNJ10 (Figure 1) 
(Ambrosini et al., 2014). The twin sibs displayed spasms and severe impairment of social 
interaction and communication, consistent with a diagnosis of PDDNOS (pervasive developmental 
disorder not otherwise specified; regressive onset). They had language delay, and their cognitive 
development was moderately delayed. In addition, both children showed electrocardiogram (ECG) 
features compatible with a Short QT type 3 Syndrome (SQT3). 
  
Fig.1 Mutation detection by sequence analysis of the 
family harboring a novel mutations in 
black symbols represent propositi and slash deceased individual. (B)
showing the heterozygous c.1037A>C transition (
variant in propositi compared to the sequence of a healthy individual (WT) 
A      
 
Specific Comments 
Autism-Epilepsy Phenotype is characterized by high clinical and pathophysiological variability. 
Within its extreme heterogeneity, the identification of 
rectifying K+ channel Kir4.1 (Sicca et al., 2011) has suggested 
pathogenesis of the disorder. We have therefore extended the screening 
encoding Kir channels (KCNJ16, and KCNJ2) 
KCNJ10 are relatively frequent in this sample (10.8%). Allel
group of patients is 2%, that is higher than the
(EVS; http://evs.gs.washington.edu/evs/). 
0.29% in our sample, higher than data found in EVS (
Conversely, the allele frequency of the R271C 
suggesting that this change could be
This common variant has been 
(Buono et al., 2004). In our series, individuals carrying variants 
association with seizures, particularly spasms. 
sample, with complete remission of epilepsy
part of severe forms of epileptic encephalopathies
KCNJ2 coding region. 
KCNJ2. Squares are males and circles females; solid 
arrow-headed), predicting a novel p.K346T 
 B     
                      
gain-of function defects 
a possible involvement in the 
in a larger sample, and found
e frequency of the R18Q variant in our 
 1.33% reported in exome variant server database 
The allele frequency of the V84M and R348H 
0.0077% and 0.0615%, respectively
was 2,86% in our study, lower than in EVS 
 a frequent polymorphism without obvious clinical significance. 
proposed to be associated with a higher resistance to epilepsy 
in KCNJ10
Unexpectedly, spasms had a good prognosis
 that is unusual since this type of seizures are usually 
. A relatively good prognosis
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 that variants in 
was each 
). 
(4,76%), 
 showed a significant 
 in our 
was particularly seen 
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in individuals carrying R18Q, R271C and R348H variants in KCNJ10. Interestingly two patients 
carrying the R348H and R271C variants, respectively recovered suddenly from spasms during a 
fever, lending hand to the hypothesis that body temperature might affect channel activity or its 
interaction with other molecular partners. Functional assays using cellular models in basal 
conditions and after modification of medium temperature  are ongoing . 
4.2 GENETIC ANALYSIS OF THE HEPACAM GENE IN MAEP 
A subset of our AEP patients had also macrocephaly. To investigate if variants in GLIALCAM 
(recently associated with macrocephaly and megalencephalic encephalopathy) or in PTEN (mutated 
in macrocephaly/autism syndrome; MIM 605309), could account for a proportion of our patient, we 
analyzed 81 individuals with ASD (50 AEP and 31 ASD “simplex”), 31 of them with concurrent 
macrocephaly (Tab.3).  
Table 3 Clinical sample of HEPACAM analysis 
 
Among macroencephalic individuals, 6/31 (19%) were labeled “extreme” considering that their 
head growth was above the 99.7th percentile. Whilst we did not identify any nucleotide variant with 
presumable pathogenic effects, we detected several single nucleotide variants (SNV) already 
reported in polymorphic databases. In particular, we found two non-synonymous variations, 
 AEP with 
Macrocephaly 
AEP without 
Macrocephaly 
ASD “simplex” with 
Macrocephaly 
ASD “simplex” 
without Macrocephaly 
Sample size 25 25 6 25 
Gender 
- M 
- F 
 
20 (80%) 
5 (20%) 
 
21 (84%) 
4 (16%) 
 
4 (66.7%) 
2 (33.3%) 
 
24 (96%) 
1 (4%) 
Age (years) 
- range  
- mean; SD 
 
2.9-20.8 
9.7; 5.2 
 
4.0-15.7 
7.6; 3.0 
 
3.0-9.9 
5.3; 2.4 
 
2.4-10.0 
5.2; 1.8 
AEP subtype: 
- Seizures 
- EEG abnormalities 
without seizures 
 
13 (52%) 
12 (48%) 
 
13 (52%) 
12 (48%) 
 
- 
- 
 
- 
- 
Age at seizure onset 
-range 
-mean; SD 
 
3.0-17.9 
9.2; 4.9 
 
0.4-15 
4.5; 4.4 
 
- 
- 
 
- 
- 
Type of seizures 
-Focal 
-Generalized 
-Spasms 
 
10/13 (76.9%) 
3/13 (23.1%) 
- 
 
7/13 (53.8%) 
4/13 (30.8%) 
2/13 (15.4%) 
 
- 
- 
- 
 
- 
- 
- 
Type of EEG 
abnormalities 
-Focal 
-Multifocal 
-Diffuse 
 
 
15/22 (68.2%) 
6/22 (27.3%) 
1/22 (4.5%) 
 
 
14/23 (60.9%) 
9/23 (39.1%) 
- 
 
 
- 
- 
- 
 
 
- 
- 
- 
 namely, p.M218V (rs10790715) and p.N324S (
allele occurred in 75% of the cases, whereas 
that mirrored what has been reported in EVS, with no
characteristics (such as presence of macrocephaly and/ or seizures/EEG abnormalities)
changes had a likely benign effect upon in silico prediction analyses. In fact p.M218V result to be 
benign because the SIFT score was 1, Polyphen showed a score of 0.00. Similar results were seen 
for p.N324S with Polyphen and SIFT scores of 0.00 and 0.38, respectively. Additional anal
MutationTaster indicated that both variants behave as benign polymorphisms. 
screening of PTEN in the whole 
abnormalities, revealed the presence of a novel heterozygous
(Figure 2) in a single case with “extreme” macrocephaly, autism, intellectual disability and 
of a first unprovoked seizure (Marchese et al., 2014). 
Fig.2 DNA sequence electropherograms showing the novel frame
(c.43delA, black arrowhead in A), and blast
black) and the mutant protein (in red) (B
 
The boy harboring PTEN mutation
pregnancy and delivery. He experienced, since the first year, poor social interaction and 
communication. Psychomotor development was delayed and he walked without support at 30 
months. At age 5.9 years, he exhibited a first generalized tonic
valproic acid (VPA) treatment. When he came to our attention, at age 6
showed diffuse hypotonia, absence of speech, moderate intellectual disability, severe behavior 
rs116102273). In our group of patients, the 
the p.S324 was present in 3.10%, 
 significant correlation
set of ASD-macrocephaly, either with or without epilepsy
 frameshift (c.43delA; p.R15Dfs*9) 
 
shift mutation in 
 alignment of the wild-type PTEN protein (in 
) 
 was born at term, from unrelated parents, after uneventful 
-clonic seizure and under
.7 years, clinical evaluation 
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Conversely, genetic 
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a history 
PTEN 
went 
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problems (frustration intolerance, aggressive behaviors), stereotypies and severe disorder of social 
interaction consistent with DSM-IV-TR criteria for ASD. Head circumference was 4.24 SD above 
the mean (> 99.7th percentile, “extreme” macrocephaly). He was still under VPA therapy, but had 
not experienced additional seizures. Wake electroencephalogram, brain MRI, karyotype, analyses 
for alterations associated with Fragile X mental retardation syndromes (FRAXA and FRAXE types) 
were normal. The new mutation in PTEN detected in this boy was not reported in public mutation 
databases, and it predicts an early stop codon and a severely truncated protein (Figure 2B). Since 
parents refused genetic testing, we could not determine whether the variant arose de novo.  
Specific Comments 
GlialCAM (glial cell adhesion molecule) is an Ig-like protein of still poorly characterized function, 
possibly involved in cell-matrix interactions and in cell motility (Favre-Kontula et al., 2008). It is 
predominantly expressed at cell-cell contacts between end-feet of astrocytes, and probably between 
oligodendrocytes and astrocytes (van der Knaap et al., 2010). Disease-causing mutations are 
associated with a phenotypic spectrum including macrocephaly, leukoencephalopathy, and epilepsy, 
with or without autism, as well as intellectual disability and psychomotor deterioration. GlialCAM 
forms homo- and hetero-complexes that are reduced by MLC-related mutations with ensuing 
defective trafficking to cell junctions (López-Hernández et al., 2011). GlialCAM has been recently 
identified as a Cl− channel ClC-2 partner, targeting it to cell junctions and modulating its 
conductance (Jeworutzki et al.,2012). CLC-2 is a hyperpolarization-activated and osmosensitive 
channel (Gründer et al., 1992; Thiemann et al., 1992) possibly playing a role in glial-mediated fluid 
and ion homeostasis, and in the maintenance of low extracellular potassium during high neuronal 
activity (Jeworutzki et al.,2012; Blanz et al., 2007; Fava et al., 2001; Makara et al., 2003). Similar 
to Kir4.1 defects, which predispose to AEP by altering the astrocytic-dependent potassium 
buffering (Sicca et al., 2011), a defective ion trafficking due to GlialCAM mutations might cause 
osmotic imbalance and fluid accumulation (Jeworutzki et al.,2012; Brignone et al., 2011; Duarri et 
al., 2011) leading to the aforementioned macrocephalic related spectrum of diseases. Taken 
together, these evidences led us to consider testing GLIALCAM in AEP associated with 
macrocephaly. Our negative  findings speak against a clear association with autism,  macrocephaly 
and seizure susceptibility, although we  cannot completely exclude a minor contribution or 
participation to a more complex dysregulation of astrocyte  homeostasis and cell growth in AEP. 
Finally, we also found a novel mutation  in PTEN already associated with several cancers as well  
as non-tumor phenotypes, including macrocephaly and  ASD (Herman et al., 2007; Butler  et al., 
2005; O’Roak et al., 2012). PTEN is an important negative regulator  of PI3K/AKT/mTOR 
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signaling pathway, which plays roles in controlling cell growth, survival and proliferation (Li and 
Sun, 1998; Pezzolesi et al., 2007). Mutations in genes of this pathway have  been associated with 
other conditions encompassing epilepsy and/or ASD, such as the Tuberous Sclerosis complex 
(Potter et al., 2003) and other megalencephaly syndromes  (Rivière et al., 2012; Mirzaa et al., 
2013), suggesting that disinhibited PTEN/PI3K/AKT/ mTOR signaling may represent a key 
mechanism implicated  in the pathogenesis of ASD, seizures and brain  overgrowth. Mice with 
targeted inactivation of Pten in differentiated neurons of the cerebral cortex  and hippocampus also 
demonstrated macrocephaly,  abnormal social interaction and exaggerated responses to sensory 
stimuli (Kwon et al., 2006). Ablating Pten broadly during  developmental stages causes premature 
death in mice, often accompanied by severe epileptic activity (Zhou et al., 2012). Thus, although 
rare, PTEN remains a candidate in AEP with  extreme macrocephaly (termed MAEP).   
4.3 NGS DATA AND THE USE OF ASTROCHIP TO DISENTANGLE AEP GENETICS   
We designed a gene panel containing the coding  of a set of 35 highly connected proteins involved 
in the modulation of astrocyte-neuron communication at tripartite synapse using information from a 
specific literature search, and connected in either functional or physical interactions with Kir4.1 (or 
among themselves) using the STRING database (http://string-db.org/) (Figure 3). Proteins 
description and their role in synaptic function and plasticity are summarized in Table 4.  
 
 
 
 
 
 Fig.3 Protein–protein interaction networks predicted by STRING using as input all 35 genes 
and the three Kir channels (Kir4.1, Kir2.1 and Kir5.1)
 
 
 
 
 
 
 
 
 
Table 4. List of the proteins explored through the targeted gene panel, and description 
main contribution to tripartite synapse physiology
 
PROTEIN GENE 
AQP4 AQP4 
Forms a water
regulates body water balance and 
SNTA1 SNTA1 
Cytoplasmic p
scaffold proteins, components of the 
dystrophin
SKCa3,4 
KCNN3, 
KCNN4 
Forms a voltage
potassium channel activated by 
intracellular calcium, regulates
SAP-90 DLG4 Required for synaptic plasticity 
associated with NMDA receptor 
           
 
FUNCTION REFERNCES
-specific channel, 
mediates water flow 
Connors et al. 2004; Seifert et al. 2006
eripheral membrane 
-associated protein 
complex 
Amiry-Moghaddam et al. 2003; Connors 
et al. 2004
-independent 
 
neuronal excitability 
Wetherington et al. 2008
Horio et al. 1997
38 
of their 
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signaling 
SAP-97 DLG1 
Essential multidomain scaffolding 
protein, recruits channels, receptors 
and signaling molecules to discrete 
plasma membrane domains 
Horio et al. 1997 
Caspr2 CNTNAP2 
Seems to demarcate the 
juxtaparanodal region of the axo-glial 
junction 
Peñagarikano et al., 2011 
GLAST-1 SLC1A3 Transports L-glutamate and also L- 
and D-aspartate, essential for 
terminating the postsynaptic action of 
glutamate 
Seifert et al. 2006; Wetherington et al. 
2008 EAAT2 SLC1A2 
ATP1A2 ATP1A2 
Catalyzes the hydrolysis of ATP 
coupled with the exchange of sodium 
and potassium ions across the plasma 
membrane. This action  provide 
energy for active transport 
Pellerin and Magistretti 1997; Rose et al. 
2009 
SLC12A2 SLC12A2 
Mediates sodium and chloride 
reabsorption. Plays a role in the 
regulation of ionic balance and cell 
volume 
Seifert et al. 2006; Jayakumar et al. 2010 
GS GLUL 
Catalyzes the synthesis of glutamine 
from glutamate and ammonia 
Albrecht et al. 2007 
mGluR3,5,8 
GRM3 
GRM5 
GRM8 
Receptor for glutamate, the activity is 
mediated by a G-protein that inhibits 
adenylate cyclase activity 
Seifert et al. 2006; Aronica et al. 2000 
GluR-1 GRIA1 Ionotropic glutamate receptor 
Seifert et al. 2006; Wetherington et al. 
2008 
GluN1-
2A,B,C,D 
GRIN1 
GRIN2A 
GRIN2B 
GRIN2C 
GRIN2D 
It mediates neuronal functions in 
glutamate neurotransmission. It is 
involved in the cell surface targeting 
of NMDA receptors 
Seifert et al. 2006; Wetherington et al. 
2008; Endele et al. 2010 
SAP-102 DLG3 Required for learning most likely Leonoudakis et al. 2004 
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through its role in synaptic plasticity 
following NMDA receptor signaling 
VAMP3 VAMP3 Involved in the targeting and/or 
fusion of transport vesicles to their 
target membrane. 
Bezzi et al. 2004; Montana et al. 2006; 
Wetherington et al. 2008 
VAMP2 VAMP2 
SytIV SYT4 
Involved in Ca2+-dependent 
exocytosis of secretory vesicles 
through Ca2+ and phospholipid 
binding 
MUNC-18-1 STXBP1 
Participates in the regulation of 
synaptic vesicle docking and fusion, 
possibly through interaction with 
GTP-binding proteins 
CX43 GJA1 Gap junctions allow the transport of 
ions and metabolites between the 
cytoplasm of adjacent cells 
Nagy et al. 2004; Seifert et al. 2006; 
Wetherington et al. 2008 CX30 GJB6 
AK ADK 
ATP dependent phosphorylation of 
adenosine, serves as a potential 
regulator of concentrations of 
extracellular and intracellular 
adenosine 
Etherington et al. 2009 
TGFR-1,2 
TGFBR1, 
TGFBR2 
Receptors bound  TGF-beta, 
transducing the TGF-beta signal from 
the cell surface to the cytoplasm 
Seifert et al. 2006; Ivens et al. 2007 
VGluT-1,2 
SLC17A7 
SLC17A6 
Mediates the uptake of glutamate into 
synaptic vesicles at presynaptic nerve 
terminals 
Wetherington et al. 2008 
EK8 EPHA4 
Receptor tyrosine kinase which binds 
membrane-bound ephrin family 
ligands, leading to contact-dependent 
bidirectional signaling into 
neighboring cells 
Murai et al. 2011 
EFL-2 EFNA3 
Cell surface GPI-bound ligand for 
Eph receptors 
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Using a 30X read-depth and QC>20 to filter out SNVs, we covered 98% of coding exons, the 
remaining 2% being filled in with Sanger sequencing. On the whole, we identified a total of 873 
gene variants including 650 SNVs, 223indels, and sorted them as follow.  Group 1: Predicted-
deleterious coding variants.  Group 1 included a total of 13 changes in 11 patients. Seven patients 
showed rare (class A) or previously unknown (class B) predictably deleterious missense variants 
located in GJA1, SLC12A2, SNTA1, EFNA3, CNTNAP2, EPHA4, and STXBP1. We also detected 
two high-frequency variants (class C) in DLG1 in 6 individuals. Table 5 lists the changes identified 
in this group of children and their major clinical findings. NGS data were searched for in the parents 
by Sanger sequencing, and in 8/11 patients were found to segregate without preferential parent of 
origin.  Group 2: Predicted-deleterious non-coding variants.  Group 2 included 36 non-coding 
predictably deleterious variants in 61 patients. Table 6 shows possible associations between specific 
variants and phenotypic subgroups. We observed that the AEP group, with respect to the “simplex” 
ASD status, was associated with a higher rate of variants in SLC17A6 (p=0.013), and that this 
association was also seen in MAEP (p=0.012). Variants in GLUL and KCNN3 were also associated 
with the AEP status, regardless of the presence of macrocephaly(p=0.002 and p=0.001, 
respectively) whereas GRM8 mutations were often seen in the presence of macrocephaly (p=0.028).  
Groups  3 and 4: Non-predicted-deleterious, coding and non-coding variants.  The remaining 822 
variants emerging in the targeted NGS were defined as non-deleterious and included 115 changes in 
coding exons (78 synonymous, 33missense, 2 indel,1 nonsense, and 1 frameshift, Group 3) and 707 
in non-coding regions (490 SNVs and 217 indel, Group 4). The functional consequences of changes 
in groups 3 and 4 were unclear and genotype-phenotype relationships to ASD or epilepsy remain 
uncertain. 
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Table 5. Major clinical features in patients with Group 1 changes (predictably deleterious 
variants in coding regions).  
Pt: patient; Cat: category; Nucl: Nucleotide variant; Prot: Protein variant; I: Inheritance (P=paternal, 
M=maternal, U=unknown); G: Gender (M=male, F=female); EEG: abnormal EEG (Y=Yes, 
N=No); Sz: Seizures (Y=Yes, N=No); Macro: Macrocephaly (Y=Yes, N=No); Reg: Regression 
(Y=Yes, N=No); ID: Intellectual disability (N=No, B=Borderline, M=Mild-Moderate, S=Severe). 
 
  
Pt Gene Cat 
Transcript 
Variant 
Prot I G EEG Sz Macro Group Reg ID 
1 GJA1 A c.826G>A A276T M M Y Y Y MAEP N N 
2 SLC12A2 A c.2589G>C L863F U F Y N Y MAEP Y S 
3 
SNTA1 
DLG1 
B 
C 
c.688G>A 
c.2456G>A 
D230N 
R819Q 
P 
P 
F Y Y Y MAEP N M 
4 EFNA3 B c.664C>G L222V P M Y Y Y MAEP Y N 
5 DLG1 C c.2762C>T P921L U M U Y Y MAEP Y M 
6 DLG1 C c.2762C>T P921L P M Y Y Y MAEP N S 
7 DLG1 C c.2762C>T P921L U M Y N Y MAEP N S 
8 DLG1 C c.2762C>T P921L P M Y N Y MAEP Y M 
9 CNTNAP2 B c.3179C>A A1060E P M Y N N AEP Y B 
10 EPHA4 A c.2324C>T P775L P M N N N 
“simplex” 
ASD 
N N 
11 
STXBP1 
DLG1 
B 
C 
c.530C>T 
c.2762C>T 
A177V 
P921L 
M 
P 
M N N N 
“simplex” 
ASD 
N N 
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Table 6. Statistical analyses on predicted-deleterious non-coding variants (number of variants 
and phenotypic features). Legend: n=number of different variants detected in classes D, E, and F 
for each gene; mean=mean of the number of different variants detected in classes D, E, and F for 
each gene, and in each subgroup (MAEP, Non-MAEP, AEP, “simplex” ASD); SD: standard 
deviation;   t-test: MAEP vs Non-MAEP, and AEP vs “simplex” ASD: asterisks indicate statistical 
significance (p <0.05); ns: not statistically significant. 
  
Total sample     
(61 subjects) 
MAEP 
(38/61) 
Non-MAEP 
(23/61) 
t-test 
(p) 
AEP  
(46/61) 
“simplex”A
SD (15/61) 
t-test  
(p) 
Gene Class 
Variants: 
n, mean±SD 
Variants: 
mean±SD 
Variants: 
mean±SD 
 
Variants: 
mean±SD 
Variants: 
mean±SD 
 
SLC17A6 F n=1, 0.1±0.3 0.2±0.4* 0 0.012 0.1±0.3* 0 0.013 
GLUL F n=2, 0.2±0.5 0.1±0.3 0.4±0.6 ns 0.3±0.6* 0 0.002 
KCNN3 F n=3, 0.2±0.5 0.2±0.4 0.4±0.6 ns 0.3±0.5* 0 0.001 
ADK F n=2, 0.2±0.4 0.2±0.4 0.2±0.4 ns 0.2±0.4 0.2±0.4 ns 
GRM8 E, F n=3, 1.0±0.3 1.1±0.3* 0.9±0.3 0.028 1.0±0.3 0.9±0.3 ns 
DLG3 D, F n=2, 0.1±0.3 0.1±0.3 0.0±0.2 ns 0.1±0.3 0.1±0.3 ns 
DLG4 F n=5, 2.2±1.3 2.2±1.2 2.1±1.5 ns 1.2±1.2 2.7±1.5 ns 
GRIN2A E, F n=5, 0.9±0.5 0.8±0.5 0.9±0.6 ns 0.8±0.5 0.9±0.6 ns 
AQP4 F n=1, 0.2±0.1 0.0±0.3 0.0±0.3 ns 0.1±0.3 0 ns 
CNTNAP2 E n=1, 0.0±0.1 0.0±0.2 0 ns 0.0±0.3 0 ns 
DLG1 E n=1, 0.0±0.1 0 0.0±0.2 ns 0.0±0.1 0 ns 
GJB6 D n=2, 0.1±0.3 0.0±0.2 0.1±0.5 ns 0.0±0.2 0.1±0.5 ns 
GRIA1 E n=1, 0.0±0.1 0.0±0.2 0 ns 0.0±0.1 0 ns 
GRM5 E n=3, 0.1±0.3 0.1±0.3 0.0±0.2 ns 0.1±0.3 0 ns 
GRIN2D D n=1, 0.0±0.1 0.0±0.2 0 ns 0.0±0.1 0 ns 
SLC1A2 F n=1, 0.3±0.5 0.4±0.5 0.2±0.4 ns 0.3±0.5 0.2±0.4 ns 
TGFBR2 F n=1, 0.0±0.1 0.0±0.2 0 ns 0.0±0.1 0 ns 
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VAMP2 E n=1, 0.0±0.1 0.0±0.2 0 ns 0.0±0.1 0 ns 
 
Specific Comments 
Based on previous findings on the role of astrocytic Kir channels in AEP (Sicca et al. 2011; 
Ambrosini et al. 2014), we focused this part of our study on a defined set of proteins that, along 
with Kir channels, contribute to the functioning and plasticity of the tripartite synapse, that is, the 
three-way neuron-astrocyte-neuron communication system (Smith 1994; Araque et al. 1999). This 
is a critical site for appropriate synaptic physiology and seems to be crucial for early brain 
development (Molofsky et al. 2012), and in the pathogenesis of neurodevelopmental disorders 
associated with ASD (Lioy et al. 2011; Edmonson et al. 2014) or seizures (Lioy et al. 2011; Wong 
et al. 2012; Leung 2013). In particular, astrocyte-neuron communications contribute in shaping 
predisposition to epileptogenesis (Seifert et al. 2006; 2013), mainly due to their involvement in 
glutamate transport and release, in potassium buffering, and interstitial volume control 
(Wetherington et al. 2008; Benarroch 2009; Ambrosini et al. 2014). The sample study consisted of 
children satisfying stringent criteria for the MAEP endophenotype (Valvo et al. 2013) to increase 
the chance to get salient genetic information in a condition where cranial overgrowth predisposes to 
seizures, and where epilepsy/EEG paroxysms and ASD are comorbid (Tuchman et al. 2013). 
The results of our deep sequencing targeted investigations in such condition suggest the following 
considerations. Using a 30X read depth as cutoff, we detected rare or previously unknown variants 
in the coding regions of SNTA1, GJA1, SLC12A2, and EFNA3 each in one MAEP patient.  
The GJA1/p.A276T variant in patient 1 is located in the carboxyl-terminal domain of connexin 43 
(Cx43) that mediates intracellular communication of astrocytes, and, along with Kir4.1, is 
implicated in their spatial buffering capacity. Pathological expression of Cx43 has been found in 
hippocampal specimens from humans with epilepsy (Collignon et al. 2006), and in post mortem 
brain tissues from subjects with ASD (Fatemi et al. 2008) and it seems to affect cell proliferation 
and migration during CNS development, and neuronal differentiation (Fushiki et al. 2003; Elias et 
al. 2007; Santiago et al. 2010). The latter roles are mainly mediated by its C-terminal domain, 
where the p.A276T variant is located, through either scaffolding (Cina et al. 2009) or signal 
transduction (Li et al. 2005) mechanisms. 
The SLC12A2/p.L863F variant detected in patient 2 affects the Na-K-2Cl co-transporter NKCC1, 
important in brain development and differentiation (Larsen et al. 2014). Together with Kir channels, 
NKCC1 takes part in the uptake of Na+, K+, and Cl- from extracellular spaces, and their transport 
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into intracellular compartments of neurons and glia, thus contributing to the regulation of 
extracellular volumes and cell swelling (Simard and Nedergaard, 2004; Ostby et al. 2009). The 
p.L863F lies in the NKCC1 carboxyl-terminus crucial for protein maturation, dimerization, and 
trafficking to plasma membrane (Markadieu 2014) and could impact on brain volume regulation 
and chloride homeostasis, needed for neuronal excitability and tissue epileptogenicity (Coull and 
Gagnon 2009). It is also important to recall that NKCC1-mediated chloride homeostasis is also 
critical for synapse formation and circuits integration (Ge et al. 2006; Cancedda et al. 2007), 
suggesting pivotal ontogenetic roles that well correlate with the MAEP phenotype seen in patient 2. 
The SNTA1/p.D230N found in patient 3 is in the N-terminal domain of alpha-syntrophin, one of the 
main interactors of Kir4.1. Besides its role in the muscular dystrophin-glycoprotein complex (Iwata 
et al. 2004), alpha-syntrophin also contributes to assembling ion and water channels to intracellular 
signaling pathways in neurons and participates in a variety of protein-protein interactions in the 
CNS including the subcellular distribution of Kir4.1 in astrocytes, at the perivascular end feet level 
(Amiry-Moghaddam et al. 2003; Connors et al. 2004). The p.D230N affects the PH1 domain 
involved in binding with phosphatidylinositol 4,5-bisphosphate (PtdIns4,5P2). This phospholipid 
component of cell membrane serves as substrate for a number of important signaling pathways, and 
possibly account for syntrophin membrane localization (Chockalingam et al.1999). Of note, patient 
3 also carried a variant (p.R819Q) of Discs large 1 protein (DLG1/SAP97) in class C. The p.R819Q 
occurs, in particular, in the C-terminal guanylate kinase (GK) domain that is involved in crucial 
protein-protein modular interactions (Mori et al. 2013). This variant, like SNTA1, acts as an 
important molecular scaffold for the assembly of protein complexes at synaptic junction (Fourie et 
al. 2014). DLG1 is also known to interact with PTEN, that may cause MAEP (Marchese et al. 
2014), and to mediate the activation - by viral proteins - of the PI3K/AKT/mTOR pathway (Chung 
et al. 2007). Remarkably another frequent DLG1/p.P921L change, also affecting the C-terminal 
region, was found in 5 additional patients in our study (cases 5-8, and 11), four of whom carried a 
clinical diagnosis of MAEP. It is possible to hypothesize that DLG1 could act as modifier, 
eventually through interaction with PTEN and the related mTOR/AKT pathway (Baek et al. 2013; 
Mirzaa et al. 2013; Marchese et al. 2014). 
We also detected in MAEP a deleterious variant in the Ephrin-A3 protein (EFNA3), implicated in 
modifying the properties of synapses through signaling at sites of neuron-neuron and neuron-
astrocyte contact. At these sites, ephrin-A/EphA receptor signaling can regulate glutamate 
concentration (Filosa et al. 2009), synaptic strength and plasticity, and neural proliferation and 
apoptosis (Depaepe et al. 2005), mechanisms thought to be defective in the pathogenesis of 
seizures, ASD (Martin and Manzoni 2014), and abnormal brain overgrowth, respectively. The 
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possible meaning of disturbed Ephrin-A/EphA receptor signaling in MAEP remains, however, 
partially questioned by the identification of a rare EPHA4/p.P775L change in a child (patient 10) 
who had “simplex” ASD, and neither seizures nor macrocephaly (see Table 5). 
A second consideration of our study is that mutations in genes that have been proposed as 
predisposing to ASD can also be involved in neuron-glia interactions and clustering of K+ channels 
in myelinated axons (Poliak et al. 1999; 2003). This is the case of two novel heterozygous variants 
in CNTNAP2 (p.A1060E) and STXBP1 (p.A177V), which were detected in a patient with AEP and 
normal head circumference (case 9), and in one “simplex” ASD boy (case 11), respectively. The 
role of CNTNAP2 (Contactin-associated protein-like 2), encoding a member of the neurexin 
superfamily in ASD and epilepsy is well established (Strauss et al. 2006; Bakkaloglu et al. 2008). 
The STXBP1gene is a recognized cause of Early Infantile Epileptic Encephalopathy (EIEE; Saitsu 
et al. 2008; Deprez et al. 2010; Mignot et al. 2011) but might have wider phenotypic consequences 
in neurodevelopment (Hamdan et al. 2009; Campbell et al. 2012) and warrants further 
investigations in ASD. 
A final consideration is that our conservative analyses left uncharacterized a large series of gene 
variants. We have no functional tools at the moment to consider them as “genetic noise” or to 
speculate on their possible minor contribution in ASD or comorbid MAEP or AEP. Understanding 
their biological role and their putative impact on phenotype diversity or disease risk will be a future 
challenge. However, we found interesting that Group 2 variants segregating with the comorbid 
MAEP/AEP subgroups (see Table 6) belong to proteins specifically involved in glutamate transport 
and metabolism (SLC17A6, GRM8 , GLUL), as well as in potassium conductance (KCNN3). This 
observation provides further rationale in stratifying ASD patients through an epilepsy-based clinical 
criterion. 
We are aware that the approach used in this part of the study has several limitations, including 
exploration of less than 0.2% of the human proteome,one of the possible mechanisms involved in 
ASD conditions, and analysis of a relatively small sample of individuals (although highly selected 
in clinical terms). Also, investigation in NGS only of the coding regions might have missed 
important regulatory regions, though we recognized that there is lack of sufficient tools to decode 
those variants at the present time. On the other hand, extensive whole genome and large exome 
screenings in unselected ASD have not allowed depicting the entire landscape of ASD genetics, 
mainly due to its extreme heterogeneity and pleiotropy, and the complex multifactorial nature of the 
disorder (Buxbaum et al. 2012; Jeste and Geschwind 2014), and largely failed in identification of 
major etiology in the disorder. Probably, a more precise contextualization of genetic variant in 
clinical scenario might improve the significance of such large set of data now available.  
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4.4 IN VIVO MODELING OF KCNJ10 MUTATION R18Q 
In order to add information on the consequences in vivo of the R18Q allele in KCNJ10, we initially 
targeted the splice site of the ZF kcnj10a with a MO, as described (Mahmood et al., 2013) to obtain 
gene knock-down. As seen by others, we observed macroscopic abnormalities in organ 
development in morphants (Figure 4) and an increased frequency of spontaneous contractions in 
30hpf embryos (Mahmood et al., 2013). 
Fig.4 kcnj10a morphant phenotype showing kidney defect and  kcnj10a morphants. The 
arrow indicate an enlargement of the swim bladder and pronephric duct area in morphants. 
 
 
In order to test in vivo the R18Q mutation, we injected 1-cell stage eggs with both MO and 
equimolar amount of either human Kcnj10 WT capped-RNA (cRNA) or human Kcnj10 R18Q 
cRNA, and compared spontaneus contractions in 30hpf embryos with uninjected embryos and the 
above described morphants. Statistical analyses using Mann-Whitney U-test  (significance set at 
p<0.05) revealed that there is an increase in spontaneous contractions in embryos injected with only 
MO, and that co-injection with the human cRNA harboring the R18Q associated with AEP could 
not complement this phenotype (Figure 5). Expectedly, WT cRNA reverted the number of 
spontaneous contractions to basal levels (Mahmood et al., 2013) . 
Fig.5 Number of spontaneus contractions (registration time 30sec) in 30hpf embryos. 
Embryos injected with MO and MO+R18Q cRNA showed an increase of spontaneus 
contractions, a phenotype that was not seen in unjected and MO+WT cRNA injected embryos 
(* p<0.05) (A). Frames represtenting contractions in 30hpf embryos injected with kncj10a 
morpholino (B) 
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A 
B  
 
Specific Comments 
Adopting an in vivo model validated for alterations in Kir4.1 channel, we demonstrated that the 
variant R18Q in the human KCNJ10 gene (Sicca et al., 2011) could exert phenotypic alterations in 
terms of locomotion and tail flicking. This adds further evidence to the established pathological 
effects of the R18Q variant, already seen in  vitro (Sicca et al, 2011) and, when combined with 
clinical data in AEP children, and with the biochemical effects of R18Q in human astrocytoma cell 
lines ongoing in our laboratories (FS, FMS, and AA, personal communication), it might lend hand 
to the speculation that homozygous R18Q might cause a more aggressive phenotype in children 
(such as, for example, the EAST syndrome) and if heterozygous predispose to early-onset seizures, 
with a benign course, and ASD  It is of interest that increased spontaneous contractions consistent 
with hyperexcitability (which probably leads to epilepsy) was seen at similar extent in morphants 
and in R18Q strains, suggesting that the gene variant predictably knock-down Kir4.1 function ― 
though we cannot discriminate between functional null and ultra low protein levels ― and could be 
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useful in pharmacological attempts to reverse the phenotype. Of note, the zebrafish model of EAST 
syndrome presented earlier (Mahmood et al., 2013) displays locomotion defects such as increased 
circling, frequent movement of the mouth and eyes of the morphants at 120hpf,  bursts of speed and 
laboured movement that were easily recorded using commercially available software analyses 
(Baraban et al., 2005), and worth exploring in the R18Q strain, and it didn't rescue the phenotype 
caused by MO. In a previous work it was demonstrated that antisense MOs directed against kcnj10a 
resulted in several CNS phenotypes resembling EAST syndrome in humans, seizures, and several 
movement abnormalities consistent with ataxia In particular the authors showed that spontaneous 
contractions were rescued by co-injection of human WT KCNJ10 which was also confirmed by our 
experiments. The rescue of the phenotype proved the specificity of antisense MO, as well as 
functional equivalence of ZF Kcnj10a with the human protein in the CNS, suggesting that ZF 
Kcnj10a also functions to regulate glial extracellular K+ levels (Mahmood et al., 2013). We also 
replicated the kidney involvement, in addition to the brain phenotypes. In fact these model was 
described as the first model of EAST syndrome, whereas individuals with EAST syndrome exhibit 
salt loss, kcnj10a morphants retain water, reflecting the different role of the kidneys in this 
freshwater fish, namely to excrete water (Drummond, 2005).   
4.5 FUNCTIONAL MODELS OF AEP: STUDIES IN ZF stxbp1 MUTANT   
Gene Expression   
The zebrafish Stxbp1a amino acid sequence (including stop codon) shares 87.2% pairwise identity 
with human STXBP1. Zebrafish Stxbp1b amino acid sequence, on the other hand, is only 78.5% 
identical to human STXBP1.Zebrafish stxbp1a and stxbp1b are both expressed broadly in the larval 
zebrafish brain (Figure 6).  
 Fig.6 Expression of stxbp1a and 
 
CRISPR Mutation   
We identified F1 zebrafish (offspring of the CRISPR/Cas9
and raised offspring of a single F1 fish to generate a stable line. These offspring
sequenced to confirm that they shared an identical mutation
revealed that the mutant allele is a 4 base
12,099,017) causing a frameshift in exon 8 of the primary stxbp1a 
(ENSDART00000015629), and predicted
Fig.7 Sequencing the novel stxbp1a
introduced at the zebrafish stxbp1a 
premature stop codon. 
stxbp1b mRNA in zebrafish
-injected fish) with mutations in 
 in ZF stxbp1a. Cloning and sequencing 
-pair deletion (Zv9 Chromosome 21: 12,099,014
ly causing a premature stop codon (Figure 7
-
s3000
 mutant allele revealed a 4 base pair deletion, 
target site, which creates a frameshift a
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transcript 
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Zebrafish Phenotype 
 Homozygous stxbp1as3000/s3000 mutant zebrafish show a dramatic failure of development and 
behavior. In fact the homozygous mutant larvae are immobile and fail to hatch by 5dpf, while the 
heterozygous larvae are morphologically normal (Figure 8).  
 
 
Fig.8 Morphological aspect of the larvae at 4dpf 
           
 
 
 
 
 
 
 
 
 
 
 
Tracking of 10 representative 5 dpf larvae of WT and stxbp1as3000/+ during 10 minutes of recording, 
showed that the velocity of larvae was no significantly different in wildtype and heterozygous 
mutant (Figure 9A). In response to a 10-sec high-intensity light stimulus, heterozygous mutants 
showed decreased activity compared to wild-type fish (Figure 9B). 
 
 
 
  
Fig.9 Behavior analysis on 5dpf larvae
A  
 
 
 
 
 
(n=23 WT, 45 Het, 21 Mut; two-tailed t
B  
 
 
  
 
 
 
 
(n=23 WT, 45 Het, 21 Mut; two-tailed t
Larval zebrafish (5dpf) were placed in individual wells of a flat
acclimated to the Daniovision recording chamber. 
comparison to wild type fish. In a 
mutant did not show any detectable movemen
 
-test, p=0.131). 
-test, p=0.042) 
-bottom 96
Then, we explore how mutant larvae moved in 
24- hour- movementtracking, . most homozygous 
ts during this period (Figure 10
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-well plate and 
stxbp1as3000 
), suggesting that 
 knockout of stxbp1a impairs significant
and additional behavioral tests in
Fig.10 Tracking of the movements in 24hpf of 5dpf lar
 
 
Specific Comments 
Both nonsense and missense mutations have been identified in patients with 
encephalopathy (EIEE) associated with mutations in 
and the clinical phenotypes showed several degrees of intellectual disability in combination with 
epilepsy. Dominant de novo mutations appe
case of our patient harboring a novel missense in 
modern molecular tools (namely, CRISP/Cas9 genomic editing) 
2014) able to circumvent several of the pitfalls of M
(Eisen and Smith, 2008; Bill et al., 2009
order to investigate both full and partial loss of ZF 
the human phenotype. One possible exploitation of the phenotype of mutant larvae is to investigate 
their development or their behavious in stress conditions. Several
development have been character
tissue degeneration, (2) widespread retardation of development, and (3) degeneration of the CNS, 
spreading to the rest of the body 
 movement. Efficient electrophysiological (EEG) recording 
 heterozygous stxbp1as3000 animal are ongoing. 
vae. 
STXBP1 (Saitsu et al., 20
ar to be a common feature in EIEE and 
STXBP1, (Allen et al., 2013
(Irion et al., 2014
O in characterizing specific effects of gene loss
; Kok et al., 2014; Schulte-Merker and Stainier, 2014
stxbp1a and to attempt functional correlates with 
 mutations affecting zebrafish 
ized and can grossly categorized in three classes: (1) generalized 
(Driever et al., 1996). However, it is known that, d
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epileptic 
08; Allen et al., 2013) 
this was also the 
). We therefore used 
, Yoshimi et al., 
 
) in 
ue to an ancient 
54 
 
whole-genome duplication in the ancestor of all teleost fishes, zebrafish have often two copies of 
single-copy human genes. For example, this applies to scn1laa and scn1lab, the counterparts of the 
human SCN1A gene, associated with Dravet syndrome (or EIEE type 6) (MIM 607208), and also to 
stxbp1a and stxbp1b the homologs of STXBP1. This duplication often implies that gene redundancy 
should be taken into account when subtle phenotypes are observed. The dispersion of melanosomes 
we observed in the Stxbp1a mutant larvae suggests that neuroendocrine pathways are disrupted in 
these mutants because zebrafish pigmentation is controlled by neuroendocrine processes and 
aggregation are bidirectionally regulated by hormones including melanocyte-stimulating hormone 
and melanin-concentrating hormone (Logan et al., 2006). Therefore, we also observed that by 5dpf 
zebrafish reliably sleep during the dark phase (Elbaz et al., 2013; Zhdanova, 2006) and there were 
no effect for heterozygous stxbp1a mutation in regulating circadian behaviors. Sleep disruptions are 
associated with both epileptic encephalopathies (EE) (e.g. Lennox Gastaut syndrome) (Kerr et al., 
2011) and autism (Elrod and Hood, 2015). Lack of dysregulated circadian behaviour could be in 
part due to the early developmental timepoint we investigated (5-6dpf), or a compensation by the 
remaining stxbp1b gene, or a less significant effect of STXBP1 on circadian processes if compared 
to other proteins that are altered in EIEE and autism. In our heterozygous stxbp1as3000/+  we 
observed a reduced response to a sudden light stimulus, which suggests that they have locomotor 
deficits in either the initiation of swimming bouts or in maximum speed. Larval zebrafish responses 
to light stimuli are well described (Burgess and Granato, 2007) and sudden light onset generally 
induces increased rate of routine turns (Burgess and Granato, 2007). Thus, further functional 
characterization is required for the stxbp1as3000/+ strain, also in terms of impact of seizure 
susceptibility. This could also have therapeutic consequences because larvae more than rodents are 
valuable tools in high-throughput (HTS) chemical and drug screenings (Grone and Baraban, 2015). 
5. DISCUSSION 
Identifying the relationships of complex disorders such as autism spectrum disorders (ASD) and 
epilepsy is becoming more complex due to the evolving diagnostic criteria, changing in 
classification criteria, and an evolving genetic landscape which suggest a multifaceted protein 
architecture in neurons and glia. However, information derived by study of genomic copy number 
variations (CNVs) and single gene disorders in both ASDs and epilepsies has proposed attention to 
several biologic processes some oof which relate  to brain development. Among those, genetic 
background of synapse development, stability, and function; or transcriptional regulation or even 
mechanisms related to cellular growth and proliferation are of main interest (Lee et al., 2015). 
Conditions associated with defects in potassium spatial buffering in the brain determined by 
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alterations in different K+ channels have been associated with both autism and epilepsy. The high 
degree of clinical and physiological overlap has also led to new terminology and to propose 
channelASD and channelepsy as conditions sharing similar pathomechanisms in spite of limited 
clinical overlap (Guglielmi et al., 2015). On the other hands, in spite of a rich collection of 
empirical findings accumulated over the past three decades attesting the diversity of traits that 
constitute the autism phenotypes, Sicca and colleagues have recently showed that gain of function 
alterations in Kir channels can be involved in the comorbid ASD and epilepsy, defining some of the 
biological basis of the clinically relevant AEP endophenotype. All this aside, our work hypothesis 
was to disentangle the complexity of AEP endophenotype looking at the dysregulated tripartite 
synapse as a likely relevant model of the disease. To test our hypothesis, we first looked for the 
relative frequency of gene variants in Kir channels and identified that up to 11% of highly selected 
AEP children harbored variants in those genes, and that the clinical string of the disorder was a 
significant association with seizures, particularly spasms with a good prognosis. At the same time 
we studied in vitro system a new genetic variant in KCNJ2, the gene encoding Kir2.1 channels. 
Both oocyte electrophysiological investigations and biochemical analyses in human and mouse 
astrocytes demonstrated that Kir2.1 in AEP works stabilizing the plasma membrane, binding to both 
caveolin 1 and 2 in lipid rafts, and influencing protein degradation through the ubiquitin-proteasome 
pathway. A more detailed investigations on the physiological and pathological role of Kir channels 
is, therefore, emerging and it is tempting to assess their role in vivo. By adopting easy-to-handle 
animal models (i.e., zebrafish morphants and knock-out), we provided preliminary observations in 
kcnj10a morphant ZF showing that the “relatively frequent” R18Q mutation in the human KCNJ10 
gene is unable to complement a knock-down phenotype and to overcome defects in locomotion, tail 
flicking and rapid jaw movements. Given that phenotypes observed in this AEP-related zebrafish 
can be detected in an automated manner, this model is ideal for future in vivo drug discovery, and 
could accelerate the identification of compounds worth testing a knock-in mouse model of Kcnj10, 
that is going to be generated.  
The existence of a larger set of patients without variants in Kir channels in spite of similar clinical 
features  impose interrogation of gene working in partnership with those encoding Kir proteins. 
Having defined a set of them in silico and adopted methods of massive parallel sequencing to detect 
and prioritize gene variants, we could explore the clinical features of a set of the identified variants. 
We found that a group of variants, segregating with the comorbid MAEP/AEP subgroups, belong to 
proteins specifically involved in glutamate transport and metabolism as well as in potassium 
conductance. However, only the tip of our genetic iceberg was carefully weighted in this PhD 
thesis. One interesting finding was identification of a new variant in STXBP1
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stable knock-out in the Danio rerio (Zebrafish) homologues stxbp1a and stxbp1b showed profound 
developmental problems including reduced movement, developmental delay, and decreased 
responses to light/dark transitions and will be soon tested for abnormal EEG recording. This model 
system could also be valuable to explore how common drugs affecting epilepsy in AEP children 
could impact on fish behaviour and longevity.   
STXBP1 homologs are evolutionarily conserved and play an essential role in vesicle release in 
Drosophila melanogaster (Harrison et al., 1994), Mus musculus (Verhage et al., 2000), and 
Caenorhabditis elegans (Weimer et al., 2003). Homozygous STXBP1 mutations in model 
organisms cause defects in synaptic vesicle docking and disrupt normal neural activity. 
Interestingly, heterozygous Stxbp1+/- mice did not have epilepsy but rather an increased fear 
response as measured by heart rate (Hager et al., 2014). It will be future development to explore 
how further environmental stressor can modify the social behavior and motor phenotype of mutant 
(either homozygous or heterozygous) animals. Despite progress in understanding the basic function 
of STXBP1, the mechanisms of disease in patients with STXBP1 is not yet clear. Therefore, more 
targeted and effective treatments are desired, and we would like to find an efficient means of testing 
in vertebrates.  STXBP1 mutations could contribute not only to seizures, but also to several 
comorbidities associated with epileptic encephalopathies and ASD. Disrupted sleep and metabolic 
circadian rhythms have been observed in patients with epilepsy (Laakso et al., 1993) and ASD (Hu, 
2009; Elrod and Hood, 2015). Similarly, decreased heart rate has been observed in patients with 
infantile spasms (Jansen et al., 2012), as well as autism (Pace, 2015), compared to controls.  
 
6. CONCLUSION AND PERSPECTIVES 
 
In conclusion, as a whole, this experimental work has put together competences of clinical 
neurophysiology, molecular genetics, cell biology and biochemistry, and used quite innovative 
experimental in vivo model of neurogenetic and neurodevelopmental disorders. We reported in this 
experimental doctoral thesis an even stronger genetic association between KCNJ10 and 
autism/epilepsy with intellectual disability. Our results suggest that the molecular mechanism 
contributing to disease tentatively relates to an increase in either surface expression or conductance 
of Kir4.1 channels, or both. Alike neurons, astrocytes might represent a crucial target for the 
pharmacological control of abnormal electrical discharge and synaptic function, at least in certain 
neuropsychiatric clinical conditions. Although we did not find clear pathogenic links between 
GLIALCAM variants and AEP-macrocephaly comorbidity, we dealt with a small sample of patients 
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and a minor contribution could have easily missed. On the other hand, we could corroborate the role 
of variants in PTEN and disclosed with NGS strategies a larger set of potential genes collaborating 
with Kir channels in the pathogenic steps seen in AEP. Although NGS techniques offer enormous 
opportunities to discover the genetic background of human complex disorders, the extreme 
phenotypic heterogeneity of AEP and the difficulty in recruiting pathophysiologically homogeneous 
samples, make it difficult to establish actual causative correlations. Future more “clinically 
oriented” study design and improved definition of endophenotypes are planned but could gather 
more relevant results when the myriad of expected gene variants are more properly contextualized 
and prioritized not only using rationalized bioinformatic pipeline but also more functional in vivo/in 
vitro tests. This was exemplified in our study where previous knowledge in vitro on a single variant 
(R18Q) was augmented by analyses in morphants and, more significantly, by generation of easy-to 
handle and relatively cheap fish knock-out model of  STXBP1, largely unexplored in terms of 
pathogenic consequences (Campbell et al., 2012). Indeed,from the first analyses in homozygous 
stxbp1as3000 strain we can speculate that STXBP1 contributes to disruption of development plan in 
zebrafish and to larval behavior, whereas heterozygous gene loss impairs movement under stress 
conditions. better drugs ae. The mechanicistic results we obtained will offer solid ground to more  
complete behavioural and EEG phenotyping in a mammalian system but could also favour cheaper 
and rapid highthroughput screening for molecules and drugs once the full spectrum of phenotypes 
are defined in mutant larvto , offering sufficient preclinical information to focus studies in rodents 
and eventually launch new clinical therapeutic perspectives in ASD and epilepsies. 
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